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GENERAL INTRODUCTION 
Platelets 
Blood platelets are formed by fragmentation of the cytoplasm of 
megakaryocytes which are located primarily in the bone marrow; 
therefore, platelets are small (3 to 5 ^ in diameter) anuclear cells 
which contain most of the other usual cellular organelles. The 
primary purpose of the platelet is to function as the cellular 
component of hemostasis. It performs this function by adhering to 
damaged surfaces exposed by vascular injury, Receptors for 
fibrinogen then appear on the platelet plasma membrane allowing 
fibrinogen cross-bridges to form. Accompanying this primary 
aggregation, which is reversible, is a change in the shape of the 
platelet, from discoidal to spherical with extended pseudopodia The 
contents of the platelet secretory granules are released at the same 
time as the shape change occurs. Serotonin, ADP, and other 
substances secreted in this manner are capable of stimulating other 
platelets to aggregate and blood to clot, leading to the formation of a 
hemostatic plug. Platelet derived growth factor (PDGF), which is also 
secreted at this time, is a potent mitogen which stimulates the 
proliferation of connective tissue cells as part of the normal process of 
wound healing (Rink and Hallam, 1984 and Miale, 1977). Blood plasma 
contains a PDGF-binding protein which serves to limit the mitogenic 
effects of PDGF to the area of tissue damage (Bowen-Pope and Ross, 
1984). However, the mitogenic effects of PDGF have been theorized to 
play a role in the proliferation of obstructive vascular tissue in 
atherosclerotic lesions associated with cardiovascular disease (Ross and 
Glomset, 1976). Indeed, platelets have been shown to mediate the 
accumulation of cholesteryl ester lipid droplets in cultured vascular 
smooth muscle cells. Accumulation of cholesterol lipid droplets is 
considered to be a contributing factor in the enlargement of 
atherosclerotic lesions (Kruth, 1985). This further strengthens the 
evidence that platelet metabolism is involved in atherosclerosis. 
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Because hypertension is a contributing factor in atherosclerosis, 
the response of vascular smooth muscle to manipulation of dietary 
fat composition is of great interest. The platelet has been used as a 
model for vascular smooth muscle in many investigations because the 
platelet utilizes many of the same mechanisms for stimulus-response 
coupling as does the smooth muscle cell (Rasmussen, 1986a and 
Majerus et al., 1985). Also, the platelet is an available blood 
component which makes it a preferred model for use in human 
studies, 
Activation of both platelets and smooth muscle cells is 
accomplished primarily through the receptor-coupled activation of 
phospholipase C. Phospholipase C cleaves phophatidyl inositol 4,5-
bisphosphate forming the second messengers inositol trisphosphate 
and diacylglycerol. The formation of inositol trisphosphate and the 
rise in its concentration in the platelet causes the release of calcium 
from intracellular storage compartments, and, later, the influx of 
calcium from outside the cell. The rise in cytosolic free ionized 
calcium ([Ca++]i) through the binding of calcium to calmodulin 
activates calcium calmodulin-dependent kinases which activate many 
cell enzymes by phosphorylation making them more sensitive to 
rising [Ca++]i. These enzymes include phospholipase C, phospholipase 
A2, and, also, enzymes required for the synthesis of elcosanoid 
paracrine regulators. Also activated by this mechanism is the 
enzyme myosin light chain kinase which phosphorylates the light 
chain of myosin. The degree of phosphorylation of the light chain of 
myosin determines the tonic state of the cell in both smooth muscle 
and platelets. Smooth muscles, then, are activated and contract as a 
result of the cascade of actions following receptor stimulation of 
phospholipase C action. Platelets contract, release secretory granules, 
and aggregate via the same mechanisms employed by smooth muscle 
for contraction (Rasmussen, 1986a and 1986b). However, in platelets, 
exocytosis of secretory granules does not require a rise in [Ca++]i, The 
activation of protein kinase C by diacylglycerol or phorbol esters is 
sufficient to stimulate exocytosis (Rink et al., 1983). Protein kinase C is 
stimulated when It is associated with membrane phospholipids, which 
occurs when [Ca+'*']i is increased, and diacylglycerol is synthesized by 
the action of phospholipase C. This increases the sensitivity of protein 
kinase C to calcium. Protein kinase C activates cell proteins by 
phosphorylation. The action of protein kinase C is thought to regulate 
the sustained phase of cellular response (Rasmussen, 1986a and 1986b), 
In the platelet, the predominant eicosanoid synthesized is 
thromboxane Ag (TX). TX synthesis requires the release of 
arachidonic acid from cellular phospholipids by phospholipase A2, 
followed by the actions of cyclooxygenase and thromboxane 
synthetase. All of these enzymes are stimulated by increased [Ca++]i 
(Majerus et al., 1985) and they all reside in platelet membranes 
(Carey et al., 1984). TX is a potent vasoconstrictor which stimulates 
the contraction of vascular smooth muscle by binding cell receptors 
and initiating the cascade of actions which follow activation of 
phospholipase C. TX also will recruit more platelets into action by the 
same mechanism (Rasmussen, 1986b). TX is rapidly and 
spontaneously converted into the stable and biologically inactive 
metabolite, thromboxane B2, which may be measured by 
radioimmunoassay (McCosh et al,, 1976 and Steinburg et al,, 1982), 
Overproduction or inappropriate production of TX by platelets is 
theorized to play a role in coronary vascular disease. Patients who 
have had recent episodes of angina pectoris have been shown to have 
increased transcardlac TX levels; however, it is still not clear whether 
the increased TX production near the heart is a cause or an effect of 
the angina episodes (Hirsh et al., 1981). A significant inverse 
correlation has been observed between plasma linoleic acid 
concentration and subsequent incidence of myocardial infarction, and, 
also, platelet adhesiveness (Kingsbury et al., 1974). This indicates, 
indirectly, that eicosanoid synthesis by platelets Is involved in 
cardiovascular disease, Kingsbury and coworkers suggest that, 
perhaps, individual variations in the metabolism of fatty acids may. 
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in part, effectively increase the requirement for essential fatty acids 
In some cases of human atherosclerosis. 
Both the contraction of smooth muscle and the aggregation and 
secretion of platelets are inhibited by receptor mediated activation of 
adenylate cyclase which catalyzes the synthesis of cyclic AMP, 
Indeed, activation of adenylate cyclase by prostaglandin I2, 
prostaglandin D2, and forskolin inhibits a rise in [Ca"*"^]! in thrombin-
stimulated platelets, while the presence of inhibitors of adenylate 
cyclase, epinephrine and ADP does not produce this effect (Zavoico and 
Feinstein, 1984), Cyclic AMP antagonizes the phospholipase C-mediated 
response via two pathways. Cyclic AMP stimulates the re-
sequestration of calcium in cellular organelles (Feinstein et al., 1985); 
the rise in cytosolic cyclic AMP also acts to inhibit phospholipase C 
(Watson et al., 1984). 
The state of activation of platelets and smooth muscle is the 
result of the balance between activation through phospholipase C 
mediated pathways and inhibition through adenylate cyclase-
mediated pathways, Together these mechanisms control [Ca++]i, An 
excellent example of the reflection of vascular smooth muscle tone, as 
determined by blood pressure measurements, upon [Ca++]i of platelets 
of normal and essentially hypertensive human subjects was provided 
by Erne et al, (1984b), Significant correlations were determined 
between [Ca++]i and both systolic and diastolic blood pressure 
measurements in these subjects. The same relationship was shown 
when the effect of antihypertensive therapy upon blood pressure and 
platelet [Ca'*'+]i was examined (Erne et al, 1984a). With use of 
antihypertensive drugs, blood pressure and platelet [Ca++]i were 
shown to decrease. A similar relationship probably exists in rats. In 
spontaneously hypertensive rats, circulating lymphocytes have been 
shown to have increased [Ca++]i as compared with lymphocytes of 
normal rats (Brushi et al., 1984). There is evidence that, in 
hypertensive persons, total cell calcium is increased as compared with 
normal individuals. Cooper et al. (1989) found that membrane-bound 
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calcium was increased in platelets of hypertensives which suggests 
that platelets of these persons are in a hyperaggregable state. These 
data suggest that these persons may be hypertensive due to 
abnormalities in their cellular metabolism of calcium. Another 
indication of a whole-body defect in calcium metabolism in essential 
hypertension is that supplementation with 1000 mg per day of oral 
calcium resulted in decreases in all measures of blood pressure in 
hypertensives. The same treatment had no effect upon blood 
pressure measurements of normal individuals (McCarron and Morris, 
1985). This may be, in part, due to a lack of responsiveness to 
vitamin D; because, in spontaneously hypertensive rats, depressed 
vitamin D-stimulated intestinal calcium absorption was observed in 
young rats even before the onset of hypertension (Schedl et al., 1984). 
Another important factor which also affects resting [Ca++]i is 
NaVK+ ATPase (NKA), which works to maintain the membrane 
potential of all cells by pumping out three Na"*" ions for every two K+ 
ions it transports into the cell. The relative activity of NKA may be 
controlled, at least in part, by the inhibitory action of a natriuretic 
hormone, The secretion of this hormone is controlled by the 
hypothalamus in response to increases in extracellular fluid volume 
which occurs with increased salt intake in susceptible individuals, 
The increased natriuretic hormone in circulation decreases the overall 
activity of NKA in all body cells, effectively increasing intracellular 
sodium concentrations. This, in turn, depresses the activity of the 
Na"^ to Ca++ exchanger, which is driven by the sodium electrochemical 
gradient. This results in less Ca++ being pumped out of the cells, and, 
therefore, an increase in resting [Ca^+li which would cause an overall 
increase in the tonicity of vascular smooth muscle. This is 
hypothesized to be the mechanism by which dietary sodium causes 
increased blood pressure in sensitive persons (Blaustein and Hamlyn, 
1984), 
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Dietary Fat and Platelets 
It is well established that dietary fatty acid composition affects 
platelet activity and fatty acid composition. In rats, feeding an 
increased ratio of polyunsaturated to saturated fat (P/S ratio) from 
0.02 to 0.30 in diets with fat composed of vegetable oils (corn oil, olive 
oil, hydrogenated palm oil, and hydrogenated coconut oil in 
proportions to provide the above P/S ratios) was found to cause an 
increase in platelet aggregation time (Davenas et al., 1984). These 
diets produced significant Increases in linoleic acid, but not in 
arachidonic acid, as percentages of total fatty acids. Platelets of rats 
fed the low P/S ratio diet had significantly increased percentages of 
eicosatrienoic acid and significantly decreased percentages of linolenic 
acid. When a similar experiment was performed using corn oil or 
butter as the primary source of dietary fat, platelet linoleic and 
arachidonic acid percentages were lower and the oleic acid percentage 
was higher when butter fat was the primary source of fatty acids 
(Renaud et al., 1970). Concurrent with these changes in platelet fatty 
acid composition, thrombin-stimulated platelet aggregation was 
increased in the butter fat-fed rats. Renaud et al, (1970) also reported 
that a significant correlation existed between the ratio of saturated 
and monounsaturated fat to polyunsaturated fatty acids in the 
platelets of middle-aged men and the thrombin-stimulated 
aggregation in their platelets. A similar relationship was shown to 
exist in humans who increased their dietary P/S ratio for periods 
longer than one year (Renaud et al., 1986). However, Lewis et al, 
(1981), studying platelet aggregation in the African Green Monkey, 
found that thrombin-stimulated aggregation was unaffected by an 
increase in dietary P/S ratio from 0,4 to 2.0 with dietary fat 
composed of butter, lard, and/or safflower oil. ADP-stimulated 
aggregation increased when the high P/S ratio of 2.0 was fed as 
compared with dietary P/S ratios of 0.4 and 1.0. Large "lipid-like" 
droplets were also observed in the cytoplasm of the platelets of 
monkeys fed the 2,0 P/S ratio diet. Unfortunately, platelet fatty acid 
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data were not presented so it can only be inferred from the results of 
other studies that platelet fatty acid composition was changed by the 
different diets fed. 
Winocour et al. (1987) found that differences in rat platelet 
phospholipid fatty acid composition effected by changing the amount 
and type of dietary fat fed produced no difference in the in vitro 
aggregation or survival of platelets when platelets were challenged in 
vivo by the presence of an indwelling aortic catheter. The effects of 
feeding high and low amounts of safflower and corn oil, high amounts 
of milk fats, and low amounts of undefined fat in a "stock diet" were 
compared in this study. Feeding of diets high in content of safflower 
or corn oil resulted in significant increases in platelet linoleate 
percentage and decreases in platelet oleate percentage as compared 
with diets low in safflower or corn oil, or high in milk fat, or stock 
diets. 
Resting platelet cyclic AMP and recalcification clotting time of 
whole blood were increased by an increase in dietary energy 
percentage (en%) linoleate from 2.3 to 16.7 en% in rats (Fine et al,, 
1981). These changes in platelet activity were accompanied by a 
decrease in total platelet phospholipid content per 10^ platelets as 
linoleate was increased. Data for individual fatty acids in platelets 
were also presented in absolute quantities per 10^ platelets which 
makes interpretation of the fatty acid composition changes difficult 
because there were such large differences in total platelet 
phospholipids. However, the trend for increased dietary linoleate to 
result in an increased percent of linoleate in platelets apparently did 
not occur in this study because when linoleic acid amounts per 10^ 
platelets were divided by total phospholipid amount per 10*^ platelets 
there was no obvious dietary trend. Perhaps, differences in platelet 
linoleate percentage were due to the fatty acid composition of other 
lipid classes in this study. 
Species differences, differences in the lipid composition of diets 
fed, and differences in variables measured might account for the 
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discrepancies in the results of these studies. Additionally, the P/S 
ratios fed in many of these studies are considerably higher than can 
be achieved in normal human diets which include significant amounts 
of meats and dairy products which are significant sources of 
saturated fats (Rizek et al., 1988). 
Dietary Fat and Eicosanoid Synthesis 
Because eicosanoids are synthesized from cellular fatty acids 
which are dietary essentials in mammals, namely linoleic, linolenic, 
and arachidonic acids, there has been a great amount of interest in 
the effects of differences in the diet content of these fatty acids upon 
eicosanoid synthesis. In the platelet, there is an arachidonate-specific 
acyl-Coenzyme A synthetase which may control the amount of free 
arachidonic acid available for synthesis of eicosanoids (Wilson et al, 
1982). Indeed, the in vj'tro ràte of uptake of arachidonic acid exceeds 
that of fatty acids that are found in much higher concentrations in 
plasma (oleate and linoleate) (Neufeld et al., 1983). All arachidonic acid 
in mammals must come from either dietary sources of arachidonic 
acid or dietary linoleic acid which has been elongated and 
desaturated. Because arachidonic acid is the metabolic precursor of 
many eicosanoids and because platelets actively incorporate 
arachidonic acid into their phospholipids, the platelet is a good cell 
model to use to investigate the effects of dietary fatty acid 
composition upon eicosanoid synthesis which is an important part of 
the platelet's response to stimulus. 
The platelet's eicosanoid synthesis response to differences in 
dietary percentage linoleate in rats was investigated by Sullivan and 
Mathias (1982). This study showed that dietary fat effects on TX 
synthesis were significant when platelet TX synthesis was measured 
when rats had been fed a meal and that fasting masked these effects, 
Diets were composed of beef tallow, corn oil, and/or safflower oil to 
provide from 0 to 10 en% linoleate. In fed rats, feeding of 1 to 2 en% 
linoleate diets resulted in the highest synthesis of TX. Rats fed 0 en% 
linoleate had lower TX synthesis than did those fed diets with 10 en% 
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as llnoleate. Similar relationships between eicosanoid synthesis and 
dietary llnoleate were reported for cardiac tissue homogenates of rats 
fed diets differing in llnoleate (Mathias and Dupont, 1985). However, 
eicosanoid synthesis was not affected by dietary llnoleate in the same 
manner in other tissues. 
Sprecher (1986) demonstrated that modifications in platelet 
phospholipid fatty acid composition may be induced by feeding 
semisynthetic diets which supplied ethyl llnoleate, or ethyl linolenate, 
or both of these esters as the sole source of fat in the diet. The 
differences in phospholipid fatty acid composition due to the presence 
of these esters in the diets were primarily in the content of long 
chain ^2-6 and rt-Z fatty acids. The incorporation of these fatty acids 
into platelet phospholipids altered the synthesis of TX and resulted in 
the synthesis of different eicosanoids which might modify the 
physiological function and response of platelets to various stimuli. 
Croft et al. (1984) reported results of feeding rats several dietary 
fat sources (hydrogenated coconut oil, cod liver oil, safflower oil, or 
linseed oil) which might not seem consistent with the results of 
Mathias and Dupont. In this study, feeding 20 and 40 en% fat diets 
with cod liver oil, safflower oil, and linseed oil all resulted in 
significantly higher synthesis of TX In whole blood as compared with 
rats fed diets providing the same percentages of energy from 
hydrogenated coconut oil. Because TX synthesis in whole blood 
primarily reflects TX synthesis by platelets, the results of this study 
would indicate that platelets are least active when dietary fat is 
highly saturated. This Is not consistent with the well established fact 
that highly saturated fat diets are proaggregatory, However, the 
energy percentage of polyunsaturated fat provided by these diets was 
high, and Mathias and Dupont also found that when dietary llnoleate 
provided 25% of kcal TX synthesis In whole blood was Increased. This 
indicates that an excess of dietary llnoleate could be proaggregatory 
as compared with more moderate llnoleate intakes. This indicates 
that dietary polyunsaturated fat effects on eicosanoid metabolism are 
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not consistently inhibitory, but, rather, are inhibitory only with 
moderate linoleate intakes (less than 10 en%), and stimulatory with 
higher intakes (greater than 20 en%), 
The results of all these studies indicate that there is not a 
consistent linear relationship between linoleate intake and TX 
synthesis. Differences in sample handling, eicosanoid analysis, and 
diet composition can drastically influence experimental results, Many 
of the diets fed in these studies were made by adding the fats or oils 
tested to commercial laboratory animal rations which may contain 
high concentrations of unspecified fiber, Dietary fiber can play a 
significant role in the absorption of fat (Story, 1981). Depending on the 
type of fiber and its concentration in the diet, absorption of fat may 
be decreased. This is probably due to adsorption of bile acids In the 
intestine, which are required for absorption of fats, to fiber from the 
diet. 
Modification of platelets in vitro bypasses the effects of dietary 
components on fat absorption and whole body lipid metabolism, 
Needleman et al. (1982) demonstrated that incubation of platelets with 
albumin-bound linoleic acid for 24 h resulted in an increase in the 
linoleate percentage of the total fatty acids of the washed platelets 
from 5,8% to 12.4%, Platelet arachidonic acid percentage was decreased 
concomitantly wi1;h the increase in linoleate. These changes in the 
fatty acid composition of the platelets produced a 50$ reduction in 
thrombin-stimulated TX synthesis. This suggests that linoleate 
inhibits the activity of enzymes required for synthesis of TX. 
However, the decrease in platelet arachidonic acid percentage may 
have been, at least in part, responsible for this effect because 
arachidonic acid is the precursor of TX, A similar effect was shown 
by Srivastava (1985) when platelets were incubated with linoleate 
followed by determination of platelet aggregation and TX synthesis. 
Srivastava found that the concentration of linoleate played a 
significant role in determining the amount of TX synthesized. At 
lower linoleate concentrations (up to 200 (jiM) cyclooxygenase was 
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inhibited because the synthesis of all eicosanolds measured was 
decreased. However, at higher linoleate concentrations (400 to 500 
[jiM) only TX synthesis was decreased while the synthesis of other 
eicosanolds was increased. This suggests that, at the higher 
concentrations of linoleate, thromboxane synthetase is also inhibited 
allowing the increased synthesis of other prostaglandins which are 
usually synthesized in quite small quantities. Even a small increase 
in the synthesis of these other prostaglandins due to redirection of 
their precursors by inhibition of thromboxane synthetase, which 
usually is the most active eicosanoid synthetic enzyme in platelets, 
would explain the significant increase in their synthesis, Arachidonic 
acid-induced platelet aggregation was also inhibited by these 
treatments. 
Dietary Fat and Phospholipase A2 Activity 
Because the activity of phospholipase Ag (PLA) is required for 
synthesis of eicosanolds, it is Interesting to note that liver PLA was 
found to be significantly decreased by feeding rats a diet high in 
polyunsaturated fat (15% sunflower oil, by weight) as compared with a 
diet lower in polyunsaturated fat (15% hydrogenated sunflower oil, by 
weight) (Momchilova et al., 1985), However, the degree of 
unsaturation in the hydrogenated sunflower oil was not presented, 
and the presence of trans-isomers was not determined, so that it is 
possible that more than one dietary factor was causing the results 
reported. In fact, trans, 12-linoleate fed to rats with constant 
low levels of all-^ryj-linoleate, at levels sufficient to prevent essential 
fatty acid deficiency, results in a reduction of TX synthesis by the 
rat's platelets (Hwang et al., 1982), However, because liver 
phospholipid linoleic acid was increased and oleic acid was decreased 
by the diet high in polyunsaturated fat fed by Momchilova and 
coworkers, the results of this study may indicate that decreased PLA 
activity caused by increased dietary linoleate is one of the cellular 
mechanisms for the general observation that increasing dietary 
linoleate from 2.5 to 10.0 en% results in decreased eicosanoid synthesis. 
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Another Indication that PLA activity may be reduced by 
polyunsaturated fatty acids is provided by Ballou and Cheung (1985). 
These researchers found that there is an endogenous inhibitor of PLA 
in human platelets, and that inhibitor is probably a polyunsaturated 
fatty acid, However, vitamin E may also play a role in controlling 
the activity of PLA. Douglas et al. (1986) found that when a diet 
containing a high percentage of linoleate (10% vitamin E stripped corn 
oil by weight), with or without added vitamin E, was fed to rats PLA 
was inhibited by the addition of vitamin E to the diet. This indicates 
that other dietary lipid factors, as well as polyunsaturated fatty 
acids, may be involved in regulation of PLA activity. 
Dietary Fat and NaVK* ATPase Activity 
Studies using cell types other than platelets have shown the 
effects of dietary P/S ratio differences upon NKA activity. Heagerty 
et al. (1986) found that human leukocyte NKA activity was increased 
in normotensive subjects by dietary linoleic acid supplementation 
from safflower oil. A slight, but significant, decrease in systolic blood 
. pressure was also observed with this supplementation. The increase 
in NKA activity with decreases in blood pressure corresponds well 
with the decreased NKA activity which has been found to exist in 
leukocytes from hypertensive patients (Edmondson et al., 1975 and 
Fitzgibbon et al., 1982). However, Murray and Patrick (1986) found 
that high levels of dietary polyunsaturated fat (from corn oil) effected 
a decrease in NKA activity as measured by the ouabain sensitive Na+ 
efflux rate constant of rat thymocytes as compared with the same 
measure in thymocytes of rats fed the same diet but with coconut oil 
and corn oil in a 3 to 1 ratio as the fat source. Additionally, 
Abeywardena et al. (1984) found no change in the activity of rat 
heart membrane NKA or Ca++ ATPase with feeding of a high P/S ratio 
diet (5.6) as compared with a lower P/S ratio diet (0.8). However, the 
P/S ratios of both of the diets examined by Abeywardena may be 
considered to be very high as compared with the dietary P/S ratio of 
0.6 of the average American woman in 1985 (Rizek et al., 1988). The 
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high P/S ratios of both diets fed by Abeywardena and coworkers 
may, in part, explain the lack of difference in the activity of NKA 
and Ca++ ATPase due to dietary treatment in this study. The P/S 
ratio of the diet composed of 40 en% corn oil (45% polyunsaturated) fed 
by Murray and Patrick might also be considered to be very high, as 
well, and might not reflect the result of more modest increases in 
dietary polyunsaturated fat. No reports have been found of research 
on the effects of differences in dietary fatty acid composition upon 
platelet NKA. 
Purpose of the Studies 
The studies reported in this dissertation were designed to 
determine the effects of differing levels of dietary linoleate upon 
platelet fatty acids, [Ca++]i, phospholipase As activity, and TX 
synthesis. The purpose of performing these experiments was to 
determine if a cellular mechanism for the effects of dietary fat on 
eicosanoid synthesis could be elucidated by these measures. Several 
controlled rat feeding experiments were performed. Nutritionally 
complete semi-purified diets which supplied from 3,0 to 9.0 en% 
linoleate provided by different proportions of corn oil and beef tallow 
were fed. Cholesterol content of the diets was made constant for all 
diets, by addition of cholesterol to those diets containing less beef 
tallow, so that a difference in dietary cholesterol content was not 
introduced as an additional experimental variable with the differing 
proportions of corn oil and beef tallow fed. These diets, thus, differed 
only in the fatty acid composition of the fat fed. Fat supplied 30% of 
total kcal in all diets. All diets fed were diets which would not be 
considered extreme in fat content or composition, therefore, the 
results of feeding these diets should be comparable to the effects of 
usual dietary fat composition in humans. Feeding-experiments using 
rats, such as these, are relatively inexpensive to perform and provide 
data which may be applicable to humans. To determine if the 
relationships found in rats exist in humans, a survey of humans 
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consuming self-selected diets was used, and the same measures of 
platelet activity and composition were made. 
Explanation of Dissertation Format 
This dissertation is composed of three papers, The first paper 
reports the effects of dietary linoleic acid upon platelet fatty acids, 
[Ca++]i, and TX synthesis in the rat. The second paper reports the 
effects of different levels of dietary linoleate upon platelet fatty acids, 
phospholipase A2 activity, and TX synthesis in the rat. The third 
paper reports the relationship of dietary linoleate to platelet fatty 
acids, resting [Ca++]i, phospholipase A2 activity, and TX synthesis in 
humans consuming self-selected diets. For all of the research results 
reported herein, the experimental designs, laboratory work, and 
statistical analyses were done by the Ph.D. candidate, Barbara 
Krumhardt, with the advice and under the supervision of Dr. 
Jacqueline Dupont. The papers are presented as chapters in this 
dissertation; these chapters represent three individual papers which 
will be submitted to scientific Journals for publication, with 
modifications made to conform with style guidelines required by the 
Journals. For all papers, the first author will be the Ph.D. candidate, 
Barbara Krumhardt, and the second author will be Dr. Dupont, For 
consistency and to avoid repetition, the literature cited for the 
general introduction, all three papers, the general summary, and 
appendices have been collected into one section at the end of this 
dissertation. 
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PAPER I. DIETARY FAT COMPOSITION HAS NO EFFECT ON 
CYTOSOLIC CALCIUM AND THROMBOXANE SYNTHESIS IN RAT 
PLATELETS 
Abstract 
Platelet activity is controlled, in part, by cytosolic free ionized 
calcium concentration ([Ca++]i). Regulation of platelet thromboxane 
(TX) synthesis may be by regulation of [Ca++]i, which may be affected 
by the fatty acid (FA) composition of the membranes in which ion 
transporters reside. Male non-obese Zucker rats were fed diets 
supplying 30 en% fat, Dietary fat was composed of corn oil and beef 
tallow to provide 3.0, 4,5, 6,0, or 7,5 enSK linoleic acid, with cholesterol 
added to provide equal cholesterol in all diets. Rats were fed for 30 
days with 6 rats/diet. Isolated rat platelets were assayed for FA 
composition. Resting and thrombin-stimulated platelet [Ca++]i and 
thrombin-stimulated platelet TX synthesis were measured in the 
presence or absence of extracellular calcium and aspirin, ouabain, or 
nifedipine. The percentage linoleic acid in platelet FA rose linearly 
with increasing dietary linoleate. No measure of [Ca++]i or TX 
synthesis was changed by dietary linoleate; indicating that platelet 
[Ca++]i is not modified by platelet FA composition changed by differing 
dietary linoleate. 
Introduction 
The blood platelet is a small anuclear cell which forms the 
cellular component in hemostasis when vascular injury occurs. The 
overactive platelet is theorized to play a role in the pathogenesis of 
atherosclerosis (Ross and Glomset, 1976), It is probable that dietary fat 
composition Is involved in this process because numerous studies have 
shown that inclusion of increased amounts of polyunsaturated fat in 
diets results in significant differences in the fatty acid composition of 
platelets, decreased platelet activity, and decreased synthesis of 
thromboxane (TX), the predominant eicosanoid synthesized by 
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platelets (Davenas et al., 1984; Renaud et al., 1970; Sullivan and 
Mathias, 1982; Fine et al., 1981). Indeed, a significant increase in 
transcardiac TX levels in the blood has been associated with recent 
episodes of angina pectoris (Hirsh et al., 1981). 
In recent years, there has been intense interest in the 
mechanisms involved in the regulation of cytosolic free ionized 
calcium ([Ca"*"^]!) in platelets and other cells and in the role of [Ca++]i in 
stimulus-response coupling of these cells. An excellent review of 
cellular calcium metabolism was published in a series of two articles 
by Rasmussen (1986a and 1986b). In brief, stimulation of the platelet 
occurs when an appropriate messenger binds a plasma membrane 
receptor. Through the regulatory action of a GTP binding protein, 
phospholipase C is activated. Phosphollpase C cleaves 
phosphatidylinositol 4,5-bisphosphate forming inositol 1,4,5-
trisphosphate and diacylglycerol, Inositol 1,4,5-trisphosphate effects a 
release of calcium from intracellular storage compartments resulting 
in an increase in [Ca"*"*"]!. The increase in [Ca++]i results in the 
activation of cell proteins through the action of calcium calmodulin, 
Among the proteins activated by the increase in [Ca"*"^]! are 
phospholipase C itself, phospholipase A2, and the enzymes involved in 
the synthesis of thromboxane: cyclooxygenase and thromboxane 
synthetase, All of these enzymes reside in cell membranes. The 
diacylglycerol released by phospholipase C activates cellular protein 
kinases which, in turn, activate other cell proteins. Diacylglycerol is 
thought to play a role in regulation of sustained cellular response to 
stimuli. The stimulation of protein kinases by diacylglycerol is 
required for platelet exocytosis of granules; however, an increase in 
[Ca++]i is not required for this action (Rink et al., 1983), 
NaVK"^ ATPase (NKA) is also involved in the regulation of [Ca'*"*']i. 
NKA works to maintain the membrane potential of all cells and, in 
turn, regulates the Na+ to Ca++ exchanger, which is driven by the 
sodium electrochemical gradient. Therefore, if the activity of NKA is 
reduced, an increase in [Ca"*"*"]! might occur. Increased [Ca+''']i in 
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vascular smooth muscle cells is associated with increased tonicity 
which induces increased blood pressure. Through an increase in 
natriuretic hormone caused by increases in extracellular fluid volume, 
this has been hypothesized to be the mechanism by which dietary 
salt causes increased blood pressure in sensitive humans (Blaustein 
and Hamlyn, 1984). In fact, increased [Ca++]i has been shown to be 
associated with increased blood pressure in all hypertensive patients 
tested (Erne et al., 1984b), Dietary fat may influence the activity of 
NKA; however, both increases and decreases in NKA activity and no 
effect on NKA have been shown to be associated with increased intake 
of polyunsaturated fat. Heagerty et al. (1986) found that human 
leukocyte NKA, as measured by the ouabain sensitive Na+ efflux rate 
constant, was increased by supplementation with linoleic acid from 
safflower oil. A slight decrease in blood pressure was also observed. 
Murray and Patrick (1986) fed rats low and high concentrations of 
polyunsaturated fat in diets that were high in overall fat content (40 
en%), NKA activity in thymocytes of these rats was found to be 
decreased by feeding the high polyunsaturated diet. Abeywardena et 
al. (1984) found that cardiac sarcolemma NKA activity was not 
changed by feeding a diet high in polyunsaturated fat. The study by 
Abeywardena and coworkers also investigated the effect of increased 
Intake of polyunsaturated fat upon cardiac sarcoplasmic reticulum 
Ca"*"^ ATPase, No effect of increased polyunsaturated fat was detected. 
We have found no studies reporting the effect of dietary fat 
manipulation upon platelet NKA in the literature. 
Because so many regulators of platelet [Ca++]i reside in cell 
membranes, and because enzymes involved in TX synthesis are also 
cell membrane enzymes, this study was conducted to determine if 
platelet [Ca'*'+]i and TX synthesis are affected by dietary linoleic acid 
concentrations. Platelets were chosen as the cell to study because 
they have stimulus-response coupling mechanisms which are similar 
to those utilized by vascular smooth muscle, and because, platelets 
have been implicated as playing a role in the pathogenesis of 
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atherosclerosis. In our study, diets were formulated to provide 30 
en% as fat, with from 3.0 to 7.5 en% linoleate, differing only in fatty 
acid composition. Feeding these diets to rats demonstrated that 
changes in platelet fatty acid composition caused by dietary linoleate 
had no effect on platelet [Ca+'*']i or thrombin-stimulated TX synthesis. 
Platelet [Ca++]i and TX synthesis in the presence of aspirin, 
extracellular Ca+\ ouabain, or nifedipine (a calcium channel inhibitor) 
were also unaffected by dietary linoleate. Aspirin is an inhibitor of 
cyclooxygenase which is the first enzyme in the pathway of TX 
synthesis after arachidonic acid has been freed from cellular 
membrane phospholipids by phospholipase A2. Ouabain is an inhibitor 
of NKA, Nifedipine is a calcium channel inhibitor, which is also used 
as a drug for treatment of hypertension. 
Materials and Methods 
ar%d diets 
This research was approved by the Iowa State University 
Vertebrate Animal Use Committee. Two feeding experiments were 
performed. For each experiment, 24 male non-obese heterozygotic 
Zucker rats were obtained from the Iowa State University 
Department of Food and Nutrition Animal Care Facility. For 
experiment 1, the rats were 10 wk old and had body weights of 261 to 
337 g. For experiment 2, the rats were 14 to 15 wk old and had body 
weights of 379 to 451 g. They were housed in a room maintained at 
22®C and approximately 50% humidity. They were fed Mouse/Rat Diet 
(6% fat, Teklad, Winfield, lA) from weaning until they were randomly 
assigned to experimental diets in a randomized block experimental 
design. The blocks represented the days when rats were sacrificed 
and samples were processed. 
The nutritionally complete diets fed for each experiment 
supplied 30 en% as fat. The dietary fat was composed of different 
proportions of corn oil and beef tallow to provide 3.0, 4.5, 6,0, and 7.5 
en% linoleic acid, with cholesterol added as required to provide equal 
cholesterol in all diets. The composition of the. diets is given in Table 
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1. The fatty acid composition of the corn oil and beef tallow used to 
prepare the diets was analyzed. 
For both experiments, rats were fed ad libitum with 6 rats/diet. 
Food consumption was determined for two 24 h periods after 3 wk of 
feeding diets. Tap water was available ad libitum for drinking. Rats 
were weighed weekly. After 30 d of feeding, rats were anesthetized 
with ether. Ten milliliters of blood was drawn from an exposed 
Jugular vein into a syringe containing 2 ml acid citrate dextrose 
anticoagulant (2.5 g% sodium citrate, 1.5 g% citric acid (monohydrate), 
and 2.0 g% dextrose). The rats were then killed by ether overdose. 
Platelet preparation 
Platelets were isolated from the anticoagulated blood by 
centrlfugation using a modification of the procedure of Hallam et al. 
(1984). Anticoagulated blood was first centrifuged at 700 X ^for 5 
min. The supernatant platelet rich plasma (PRP) was recentrifuged at 
700 X ^ for 5 min to remove contaminating red and white blood cells. 
The PRP was then centrifuged at 400 X g for 20 min to sediment the 
platelets. The plasma was removed, an equal volume of HEPES 
buffered saline (HBS) (145 mM NaCl, 5 mM KCl, 1 mM Magnesium 
Sulfate, 10 mM HEPES, 10 mM glucose, pH 7.4) was added, and the 
platelets were resuspended by gentle vortexlng. The platelets were 
resedimented by centrlfugation at 400 X ^for 20 min. The HBS was 
discarded and an equal volume of fresh HBS was added and, again, 
the platelets were resuspended by gentle vortexing. This resulted in 
a platelet suspension containing approximately 2 X 10^ cells/ml which 
was used for the [Ca++]i experiments. For experiment 2, a 1 ml 
aliquot of the washed platelets in HBS was frozen on dry ice for later 
fatty acid analysis. The purity of platelet suspensions was 
determined by microscopic observation of several smears of PRP 
prepared by this procedure which were stained with Wright's stain 
(Fisher Scientific, Silver Spring, MD). At least 98% of all cells observed 
were platelets. 
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Table 1. Composition of Experimental Diets 
Energy Percentage Linoleate 
Ingredient 3^0 4^5 6j0 7,5 
g/lOOg 
Beef Tallow^ 12.47 11.19 9,89 8.59 
Corn Oil^^ 1.83 3.11 4.41 5.71 
Casein ^  22.35 22.35 22.35 22.35 
Sucrose b 26.43 26.43 26.43 26.43 
Corn Starch b 26.43 26,43 26.43 26.43 
Cellulose ^  5.03 5.03 5.03 5.03 
AIN Mineral Mixture 76® 3.93 3.93 3.93 3,93 
AIN Vitamin Mixture 76® 1.11 1.11 1.11 1.11 
L-Methionine c 0,33 0.33 0.33 0,33 
Choline Chloride f 0.08 0.08 0.08 0.08 
Ascorbic Acid (antioxidant) ^  0,01 0.01 0,01 0.01 
Cholesterol (mg/lOOg)^ 0,00 1.50 2.80 4.20 
^Meat Lab., Department of Animal Science, Iowa State 
University. 
^lowa State University Food Stores: Mazola Corn Oil, Crystal 
Sugar, and Argo Corn Starch. 
^United States Biochemical Co., Cleveland, OH. 
^Teklad, Madison, WI. 
^Composition described by the AIN Ad Hoc Committee on 
Standards for Nutritional Studies (1977). ICN Nutritional Biochemicals, 
Cleveland, OH. 
fSigma Chemical Co., St. Louis, MO, 
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Fatty acid analysis 
All steps of the analysis were performed with the samples kept 
under a nitrogen atmosphere. One gram samples of beef tallow and 
corn oil were dissolved in 40 ml chloroform:methanol (2:1). A 0.5 ml 
aliquot of the solution was dried under a stream of nitrogen in glass 
culture tubes with teflon lined caps. The total fatty acids in the 
aliquot were saponified after addition of 0.5 ml water, 0.4 ml 50% 
aqueous KOH (w/v), and 1.1 ml ethanol. 
Platelet total fatty acids were saponified in the same manner 
as pure fats in tubes containing 0.5 ml suspended frozen and thawed 
platelets, 0.4 ml 50% KOH (w/v), and 1.1 ml ethanol. The tubes were 
incubated in a water bath at 60*C for 60 min for the dietary fat and 
for 30 min for the platelet samples. 
After the saponification tubes were cool, neutral lipids were 
extracted twice with petroleum ether (BP 35-65*C), Three drops of 0,1% 
bromphenol blue in ethanol were added and concentrated HCl was 
added until the color changed to yellow. Indicating a pH of less 
than 3.0. Free fatty acids were then extracted with 5 ml petroleum 
ether. The fatty acid extracts of dietary fat and liver samples were 
then dried under a nitrogen flow. The extracted beef tallow and corn 
oil fatty acids were then methylated by addition of 1 ml 14% BF3 in 
methanol (Alltech, Deerfield, ID and heating in a boiling water bath 
for 2 min. Platelet fatty acids were methylated using 0.4 ml of the 
14% BF3 in methanol reagent which was heated in the boiling water 
bath as was done with the dietary fat samples. 
After cooling, methylated fatty acids were extracted with 2 ml 
hexane, dried under nitrogen, and resuspended in 2 ml of hexane for 
the dietary fat samples and 50 ^1 of hexane for the platelet samples, 
A 1 lil aliquot was then analyzed by gas chromatography using a 
Varian 330 gas chromatograph (Walnut Creek, CA) equipped with an 
Alltech 183 x 0.32 cm column loaded with a 10% 100/120 mesh Silan IOC 
stationary phase and a 3390A Hewlett Packard Integrator (Avondale, 
PA), The nitrogen carrier gas flow rate was 18 ml/mln. The column 
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temperature was 180*C; the Injection port temperature was 220%; and 
the flame ionization detector temperature was 250®C, The peaks were 
identified by comparison of retention times with those of authentic 
fatty acid methyl ester standards (Alltech). The percentage of each 
fatty acid was determined by integration of peak areas. Trace 
components (less than 0.5% of total) were not identified or included in 
the quantitation. 
Cvtosollc calcium 
[Ca++]i was determined by using the fluorescent calcium 
indicator fura-2 by a modification of the method described by Sage 
and Rink (1986), An equal volume of 4 fjiM fura-2/acetoxymethyl (AM) 
(Molecular Probes, Inc., Eugene, OR) in HBS was added to each tube 
containing suspended platelets and the tubes were incubated for 60 
min in a Z7X water bath to allow the platelets to incorporate the 
fura-2/AM. The tubes were then centrifuged at 400 X g for 20 min 
to sediment the platelets. The fura-2/AM in HBS was decanted and 
the tubes were blotted on adsorbent paper to remove all the Fura-
2/AM not trapped within cells. An equal volume of HBS was added, 
and the platelets were resuspended by gentle vortexing, The tubes 
were then incubated in the 37*C water bath for at least 1 h to allow 
complete hydrolysis of the AM groups. Fluorescence of the fura-2-
loaded platelets was determined in a 37*C thermostatically regulated 
stirred quartz cuvette in a Model J4-8965 Amino Bowman 
Spectrofluorometer with excitation wavelength 340 nm and emission 
wavelength 505 nm (1 mm slit widths). 
One ml of suspended platelets was transferred to a cuvette and 
1 ml of test reagent for in vitro treatments was added. For 
experiment 1 the test reagents were HBS, HBS with 200 pM aspirin, 
HBS with 2 mM CaCl2, and HBS with 200 ^M aspirin and 2 mM CaCl2. 
This resulted in in vitro treatments of HBS, HBS with 100 nM aspirin, 
HBS with 1 mM CaClg, and HBS with 100 |iM aspirin and 2 mM CaClg 
for the first experiment. 
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For experiment 2 the test reagents were HBS with 2 mM CaCl2, 
HBS with 2 mM ouabain and 2 mM CaCl2, and HBS with 2 pM 
nifedipine and 2 mM CaClg. This resulted in in treatments of 1 
mM CaCl2, HBS with 1 mM ouabain and 1 mM CaCl2, and HBS with 1 
nM nifedipine and 1 mM CaCl2 for the second experiment. 
Fluorescence (F) was measured at 4.5 minutes after addition of 
the test reagent, At 5 minutes after test reagent addition, 12 U 
thrombin (Sigma) in 25 nl HBS was added to the 2 ml of platelets in 
test reagent. F was determined at 2 minutes and 4 minutes after 
thrombin stimulation. A 225 |il aliquot of the stimulated platelets 
was taken and added to 25 pil 42 mM aspirin in HBS and frozen on 
dry ice for later TX analysis. The maximal fluorescence (Fmax) of the 
fura-2 trapped within the cells was determined by adding 200 pi of 
11% Triton X-100 in water containing 0.956 g% CaCl2 (dlhydrate) to lyse 
the cells and make the final calcium concentration 1 mM. The 
minimum fluorescence (Fmin) of the fura-2 then was determined by 
adding 200 |il of 2 mM ethylene glycol-bis(p-aminoethylether)N,N,N',N'-
tetraacetic acid (EGTA) (Sigma Chemical Co., St. Louis, MO) which was 
dissolved in 3.8 g% KOH. The addition of this alkaline calcium chelator 
resulted in a pH of approximately 8,5 and served to release all 
calcium from the fura-2. 
Autofluorescence of several suspensions of pooled platelets in 
HBS, without incorporated fura-2, was determined for F, Fmax, and 
Fmin using the procedures for cells loaded with fura-2 and these 
values were subtracted from all values for F, Fmax, and Fmin in 
calculations. Additionally, a correction factor for the slight increase in 
F due to leakage of fura-2 into the suspending buffer was determined 
using several fura-2 loaded cell suspensions prepared as described 
above but with the addition of EGTA in HBS (titrated to pH 7.4) (final 
concentration of EGTA was 2.5 mM) to chelate extracellular calcium. 
Unfortunately, there were insufficient numbers of platelets available 
from each rat to determine autofluorescence for platelets of individual 
rats fed experimental diets, so values for pooled platelets from other 
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rats that had consumed standard laboratory rations were used. 
These corrections were small, however, as compared to overall 
differences in F, Fmax, and Fmin-
Calibration curves were made as described by Grynkiewicz et al, 
(1985) to determine the apparent Kd of fura-2. Briefly, a buffer 
(Buffer A) was composed of 100 mM KCl, 10 mM Na/MOPS (3-[N-
Morpholino]-2-hydroxypropanesulfonic acid, sodium salt), 10 mM 
EGTA, 30 mM KOH, and 1 pM fura-2, Addition of 10 M CaCl2 to Buffer 
A to the potentiometric endpoint as determined by calcium electrode 
made all the EGTA in this buffer into the form of K2CaEGTA (Buffer 
B). Combinations of the two buffers were then made to produce 0, 
20, 50, 100, 200, 500, 1000, 1500, and 2000 nM and 0,1 mM [Ca2+]. F 
for each of the concentrations of [Ca2+] was determined as described 
above. The apparent Kd of fura-2 derived from calibration curves of 
data collected in this manner was 221±19 nM (mean±SD, n = 6). This is 
close to the value estimated by Grynkiewicz et al. (1985) of 224 nM; 
therefore, the value determined for our instrument was used for 
calculations. 
To determine the apparent loading of fura-2 into platelets, 200 
\A of 11S5 Triton X-100 in water was added to 2 ml of suspended 
platelets and F was measured. Before cell lysis the packed cell 
volume of platelet suspensions prepared as described was about 1% as 
determined by microhematocrit centrifugation of 10-fold concentrated 
platelet suspensions. Additions of 100 nM K2CaEGTA buffer without 
fura-2 to the 100 nM K2CaEGTA buffer with fura-2 were made and F 
was measured. Comparison of the F of platelets loaded with fura-2, 
after lysis, and the F of the 100 nM KgCaEGTA buffer with additional 
fura-2, and taking into account the packed cell volume to estimate 
the intracellular volume of the platelets, indicated that loading of 
platelets was to about 37±14 pM fura-2. Because no correction was 
made for the volume of the cell membranes and organelles in the 
packed cell volume, and packed cell volume could not be accurately 
determined, the actual concentration of fura-2 in the loaded cells may 
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have been slightly higher than this because the cytosolic volume 
would be lower if the volume of organelles were subtracted. 
[Ca"""*"]! was estimated using the form of the equation of 
Grynkiewicz et al. (1985) intended for determination of [Ca+'*']i in nM at 
one excitation wavelength: [Ca++]i = Kd (F-Fmin)/(Fmax-F). 
This form of the equation for calculating [Ca++]i has also been used by 
other researchers to estimate [Ca"*"*"]! (Pritchard and Ashley, 1986). This 
equation does not account for the wavelength shift for excitation of 
fluoresence which occurs when calcium is released from fura-2. 
Thromboxane B2 assay 
Double antibody radioimmunoassay of TX using ^H-TX (New 
England Nuclear, Boston, MA) to competitively bind antibody was 
performed as described previously by McCosh et al. (1976) and 
Steinberg et al. (1982). The TX antiserum had a cross-reactivity with 
6-keto prostaglandin Fia of 20%. No correction was made for this cross 
reactivity. 
Protein analysis 
After preparation of samples for other analyses all of the 
remaining platelet suspension was frozen on dry ice and stored at 
-20®C for protein analysis which was performed later by using the 
procedure of Lowry et al. (1951). Fatty acid-free bovine serum 
albumen fraction V (Sigma Chemical Co., St. Louis, MO) was used as 
the protein standard. 
Statistical methods 
All analyses were done in duplicate for each sample. Statistical 
analyses were done using the General Linear Model, Least Squares 
Means, and Pearson Correlation Coefficients procedures of Statistical 
Analysis System, version 5.16, Cary, N.C. 
Results 
Animals and diets 
The data for rat food consumption and weight gain for both 
experiments are shown in Table 2. For the first experiment there 
was no significant difference due to diet in food consumption or 
Table 2. Food consumption and weight gain of rats fed diets with different 
linoleate concentrations 
Experiment Experiment 2^ 
Food Weight Food Weight 
Dietarv linoleic acid consumption Rain consumption gain 
en% n «/dav 2/30 davs n K/dav 2/30 davs 
3.0 6 21±1 86±5 6 19+1 56±5 
4.5 6 20±1 79+5 5 19±1 45+6 
6.0 6 21±1 80±5 6 17±1* 48±5 
7.5 6 19+1 79±5 6 19±1 42±5 
^Values are means ± SEM as determined by least squares means. 
^Values are means ± SEM as determined by least squares means. 
^Significant dietary treatment effect at P< 0.04. 
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weight gain. For the second experlnnent, the group fed the 6,0 en% 
linoleate diet consumed significantly less food per day. However, 
there was no significant difference due to diet in weight gain. There 
were no signs of essential fatty acid deficiency in any animals. 
Fatty acWg 
The results of platelet total fatty acid analysis are shown in 
Table 3. The percent llnoleic acid in platelets increased with 
increasing concentrations of dietary linoleate, resulting in an good 
correlation between the two (r = 0.758, P< 0.0001). However, only 
rats fed the 3.0 en% linoleate diet had a significantly decreased 
percentage of llnoleic acid in their platelets as compared with those 
fed the 4.5, 6.0, and 7.5 en% linoleate diets. Concurrently, the 
percentage oleic acid in platelets decreased with increasing 
concentrations of dietary linoleate (r = -0,50, p < 0,01). Rats fed the 
4.5 en% linoleate diet had the highest percentage of oleic acid in their 
platelets. This was significantly higher than the percentage of oleic 
acid in the platelets of rats fed the 6,0 and 7.5 en% linoleate diets, but 
not significantly different from that of those rats fed the 3.0 en% 
linoleate diet. The percentage oleic acid in platelets of rats fed the 3,0 
en% linoleate diet was not significantly different from that of those 
rats fed any of the other diets, Rats fed the 6,0 en% linoleate diet 
had a significantly increased percentage of myristic acid in their 
platelets as compared with those fed the 3.0 and 7.5 en% linoleate 
diets. There was no significant difference in the percentage of 
myristic acid in platelets of rats fed diets providing 4,5 and 6.0 en% 
linoleate. Arachidonic acid was significantly lower in the platelets of 
rats fed the 3.0 and 4.5 en% linoleate diets as compared with those 
fed the 6.0 and 7.5 en% linoleate diets. 
CytQ^QUc calcWm 
As shown in Tables 4 and 5, there were no significant 
differences due to diet in any measure of platelet [Ca++]i for either 
feeding experiment. Therefore, the results for all measures were 
pooled for all diets. The effects of the j'n vitro treatments for 
Table 3. Platelet total fatty acids of rats fed diets witti different linoleate 
concentrations (experiment 2) 
Dietary Fattv acid (No. Carbons: No. double bondsV 
Linoleate 14:0 16:0 18:0 18:1* 18:2** 18:3 20:3 20:4 
en% n % of total fattv acidsl 
3.0 6 1.6±0.2a 31.8±1.4 17.7±1.4 21.9+1.8^ 8.8±0.7a 0.8±0.2 0.9+0.2 16.5±l.m 
4.5 5 1.8±0.2^b 29.4±1.6 15.1±1.6 24.2±2.ia 12.0±0.8b 0.8±0.3 0.5±0.2 16.3±l.m 
6.0 6 2.3±0.2b 29.0+1.4 16.2±1.4 17.3+1.8^ 12.7+0.7^ 1.410.2 0.8±0.2 20.3±1.3b 
7.5 6 1.7+0.2^ 29.0±1.4 17.5+1.4 16.7±1.8b 14.1±0.7b 0.7±0.2 0.6±0.2 19.7+l.mb 
lvalues are means ± SEM. Values with different superscript letters for individual 
fatty acids are significantly different due to dietary treatment at Z' < 0.05 by least 
squares means. 
*Significant dietary treatment effect at P< 0.05. 
**Slgnificant dietary treatment effect at P< 0.001. 
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Table 4. Effects of dietary linoleate and extracellular CaClg 
and aspirin upon platelet [Ca*+]i in experiment 1 
In Vitro Treatment: HBS 
Dial 
[Ca++]i (nM)a 
After thrombin stimulation^ 
en% Linoleate n At reste at 2 min at 4 min 
3.0 6 126±12 802±51 1030±78 
4.5 6 133±12 742+51 1019+78 
6.0 6 127+12 687+51 1050+78 
7.5 6 131±12 765±51 1088+78 
In Vitro Treatment: HBS and 1 mM CaCls 
Diet 
[Ca++]i (nM)a 
After thrombin stimulation^ 
en% Linoleate n At reste at 2 min at 4 min 
3.0 6 128+9 728+40 1005+54 
4.5 6 126±9 783+40 1075±54 
6.0 6 125±9 743+40 1050+54 
7.5 6 130±9 747±40 1054+54 
In Vitro Treatment: HBS and 100 uM Aspirin 
msi 
[Ca++]i (nM)a 
After thrombin stimulation^^ 
en% Linoleate n At reste at 2 min at 4 min 
3,0 6 117+12 714±27 1011+47 
4.5 6 126+12 731+27 1036+47 
6,0 6 123±12 683±27 995±47 
7.5 6 125±12 682±27 1005+47 
In Vitro Treatment: HBS, 1 mM CaCl2. and 100 uM Aspirin 
msï 
[Ca++]i (nM)â 
After thrombin stimulation^ 
en% Linoleate n At reste at 2 min at 4 min 
3.0 6 127±10 828±41 1108±61 
4.5 6 124±10 752±41 1112±61 
6.0 6 118±10 708±41 937+61 
7.5 6 125±10 756±41 1045+61 
^6 U Thrombin/ml. 
Walues are means ± SEM for 5 to 6 rats as determined by least 
squares means. 
cAfter 4,5 min preincubation with test reagent. 
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Table 5 Effects of dietary llnoleate and Ion transport 
blockers upon platelet [Ca**]i In experiment 2 
In Vitro Treatment: HBS and 1 mM CaCla 
PM 
[Ca+*]i (nM)^ 
After thrombin stimulation^ 
en% Linoleate n At reste at 2 min at 4 min 
3.0 6 135+18 767+47 1054+60 
4.5 5 127±20 879±53 1031±67 
6.0 6 117+18 786+47 996+60 
7.5 6 123±18 710±47 1018±60 
In Vitro Treatment: HBS, 1 mM CaCl2, and 1 mM Ouabain 
Piet 
[Ca++]i (nM)a 
After thrombin stimulation^ 
en% Linoleate n At reste at 2 min at 4 min 
3.0 6 124+24 619+51 1157+110 
4.5 5 117+27 642+57 1091±124 
6.0 6 126+24 607+51 11681110 
7.5 6 130±24 545±51 1040±110 
In Vitro Treatment: HBS, 1 mM CaCl2, and 1 pM Nifedipine 
Diet 
[Ca++]i (nM)â 
After thrombin stimulation^ 
en% Linoleate n At reste at 2 min at 4 min 
3.0 6 126+20 127+15 156+22 
4.5 5 114±20 116±17 116±25 
6.0 6 122±20 118+15 115+22 
7.5 6 126±20 98±15 99+22 
^6 U Thrombin/ml. 
Walues are means ± SEM for 5 to 6 rats as determined by least 
squares means. 
cAfter 4.5 min preincubation with test reagent. 
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experiment 1 are shown in Table 6. The in treatment consisting 
of HBS with 100 (iM aspirin caused a significantly lower increase in 
[Ca"'"'"]! after stimulation with thrombin as compared with the increase 
in [Ca++]i observed when platelets were treated with no CaClg or 
aspirin, CaCl2 alone, or CaCl2 and 100 |iM aspirin. 
The effects of the in vitro treatments in experiment 2 are 
shown in Table 7. All three in w/zï? treatments provided statistically 
significant differences in the rise in [Ca'*"*']i. The rise in [Ca++]i was the 
least In platelets suspended in HBS plus CaCl2 with nifedipine, the 
calcium channel blocker, When HBS plus CaClg with ouabain, the 
Na+/K+ ATPase inhibitor, was used as the test reagent, a significantly 
greater rise in [Ca++]i (at 4 min after stimulation with thrombin) was 
seen than with HBS plus CaCl2 alone. However, ouabain treatment 
resulted in a slower rise in [Ca++]i than observed with HBS plus CaCl2 
alone as evidenced by the lower measurement for [Ca++]i 2 min after 
stimulation with thrombin. 
Thromboxane B2 synthesis 
No differences due to diet were observed in thromboxane 
synthesis when platelets were stimulated with thrombin, as shown in 
Tables 8 and 9, therefore, the data for all diets were pooled and the 
data were analyzed for the effect of in vitro treatments. The data 
for the effects of in vitro treatments performed in experiment 1 are 
shown in Table 10. Treatment with aspirin in HBS resulted in the 
lowest synthesis of thromboxane. Treatment with CaCl2 in HBS 
provided the highest synthesis of thromboxane. Treatment of 
platelets with both CaCl2 and aspirin resulted In no difference In 
thromboxane synthesis as compared with thromboxane synthesis in 
HBS alone. 
The pooled data for the in vitro experiments performed in 
experiment 2 are shown in Table 11, Ouabain treatment resulted in 
significantly higher synthesis of thromboxane than either other 
treatment. Thromboxane synthesis was lowered, but not 
significantly, by treatment with nifedipine. 
Table 6. Effects of in vitro treatments upon platelet cytosolic calcium in 
experiment 1 
Cytosolic Calcium (nM)^ 
After thrombin stimulation^ 
In Treatment n At reste at 2 min at 4 min 
HBS 24 130+5 749±20 1052±17 
HBS with 1 mM CaCl2 24 127+5 750+20 1046+17 
HBS with 100 jjiM Aspirin 24 123±5 703+20 1008*±17 
HBS with 1 mM CaCl2 and 100 Aspirin 24 124+5 761+20 1075+17 
^Values are means ± SEM as determined by least squares means. 
^6 U Thrombin/ml. 
^After 4.5 minutes preincubation with test reagent. 
^Significant aspirin treatment effect at /'< 0.01. 
Table 7. Effects of ion transport blockers upon platelet cytosolic calcium in 
experiment 2 
Cytosolic Calcium (nM)^ 
After thrombin stimulation^ 
In VJtro Treatment n At reste at 2 min* at 4 min** 
HBS with 1 mM CaCl2 24 125±11 781±23 1025+40 
HBS with 1 mM CaCl2 and 1 mM Ouabain 24 125±11 602+23 1099+40 
HBS with 1 mM CaCl2 and 10 piM Nifedipine 24 122+11 115±23 126+40 
^Values are means as determined by least squares means. 
U Thrombin/ml. 
CAfter 4.5 minutes preincubation with test reagent. 
^Significant ouabain and nifedipine treatment effect at /'< 0.01. 
^^Significant treatment effect at P< 0.0002. 
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Table 8. Effects of dietary linoleate and extracellular CaCl2 
and aspirin upon platelet thromboxane synthesis 
after thrombin^ stimulation in experiment 1 
In Vitro Treatment: HBS 
Diet Thromboxane synthesis 
en% Linoleate n ng/mg Platelet protein/4 min^ 
3.0 6 9.29+2.77 
4.5 6 9.36+2.77 
6.0 6 8.03+2.77 
7.5 6 12.22±2.77 
In Vitro Treatment: HBS and 1 mM CaClg 
Diet Thromboxane synthesis 
en% Linoleate n na/ma Dlatelet Drotein/4 min^ 
3.0 6 13.69+2.72 
4.5 6 18.41±2.72 
6.0 6 12.96±2.72 
7.5 6 14.66±2.72 
In Vitro Treatment: HBS and 100 uM ÂSDirin 
Diet Thromboxane synthesis 
enS Linoleate n ng/mg Platelet protein/4 min^ 
3.0 6 2.84+1.01 
4.5 6 5.19±1.01 
6.0 6 4.31±1.01 
7.5 6 2.83±1.01 
In Vitro Treatment: HBS. 1 mM CaCl2, and 100 uM Aspirin 
Diet Thromboxane synthesis 
en« Linoleate n ng/mg Platelet protein/4 min^ 
3.0 6 6.35±1.67 
4.5 5 9.36±1.88 
6.0 6 4.92+1.67 
7.5 6 8.22+1.67 
^6 U Thrombin/ml. 
^Values are means ± SEM for 5 to 6 rats as determined by least 
squares means. 
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Table 9. Effects of diets upon platelet thromboxane synthesis 
after thrombin^ stimulation in experiment 2 
In Vitro Treatment: HBS and 1 mM CaCls 
Diet Thromboxane synthesis 
en% Linoleate n na/ma nlatelet Drotein/4 min^ 
3.0 6 21.34+3.62 
4.5 5 11.45+4.07 
6.0 6 16.75±3.62 
7.5 6 19.21±3.62 
In Vitro Treatment: HBS, 1 mM CaCl3. and 1 mM Ouabain 
Diet Thromboxane synthesis 
en% Linoleate n na/mc olatelet Drotein/4 min^ 
3.0 6 30.07+4.94 
4,5 5 18,36+5.56 
6.0 6 23.15±4.94 
7.5 6 27,80+4.94 
In Vitro Treatment: HBS. 1 mM CaCIg. and 10 uM Nifedipine 
Diet Thromboxane synthesis 
enS Linoleate n ne/miz Dlatelet Drotein/4 min^ 
3.0 6 8.91±6,81 
4.5 5 7.93±7.42 
6.0 6 5.39±6,81 
7.5 6 6.22+6.81 
^6 U Thrombin/ml. 
bValues are means ± SEM for 5 to 6 rats as determined by least 
squares means. 
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Table 10. Effects of in vitro treatments upon platelet 
thromboxane synthesis after thrombin^ 
stimulation in experiment 1 
HBS with 1 mM CaCb and 100 uM Aspirin 7.2711.29 (n = 23) 
^6 U Thrombin/ml. 
Values are means ± SEM for 23 to 24 rats as determined by-
least squares means. 
•Values are significantly different due to CaCl2 treatment at P< 
0.0001. 
**Values are significantly different due to aspirin treatment at P< 
In K/Yn? Treatment Thromboxane synthesis 
HBS 
HBS with 1 mM CaCl2 
HBS with 100 liM Aspirin 
ng/mg Platelet Drotein/4 min^ 
9.73+1.26 (n = 24) 
14.93±1.26* (n = 24) 
3,79±1.26** (n = 24) 
0.001. 
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Table 11. Effects of ion transport blockers upon platelet 
thromboxane synthesis after thrombin^ stimulation 
in experiment 2 
In Treatment Thromboxane synthesis 
ng/mg Platelet Droteln/4 mlnb 
HBS with 1 mM CaClg 17.38±4.14 (n = 23) 
HBS with 1 mM CaClg and 1 mM Ouabain 24.88*±4.14 (n = 23) 
HBS with 1 mM CaCl2 and 10 \M Nifedipine 13.13±4.14 (n = 23) 
^6 U Thrombin/ml. 
Walues are means ± SEM for 23 rats. SEM was determined by 
least squares means. 
* Values are significantly different due to ouabain treatment at P< 
0.05. 
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Discussion 
The changes in platelet fatty acid composition effected by the 
composition of dietary fat are consistent with those observed by 
others (Davenas et al, 1984 and Renaud et al., 1970), These changes 
should have effected a difference in the aggregability of the platelets, 
but this parameter was not measured. 
[Ca++]i was not significantly affected by dietary linoleate 
treatment. This indicates that other mechanisms which are less 
central to platelet homeostasis account for decreases in platelet 
activity with increases in dietary polyunsaturated fat. However, the 
in vitro treatments did cause significant differences in [Ca+'*']i after 
stimulation with thrombin. 
TX synthesis was not significantly affected by dietary linoleate 
treatment. This result is contrary to expectations, because we have 
found that decreasing TX synthesis is associated with increases in 
dietary linoleate in the range of the diets fed (Dupont, 1987), Because 
arachidonic acid concentration was unaffected by dietary linoleate,-
one could associate this lack of dietary linoleate effect on TX with a 
lack of difference in precursor concentration. It is possible that the 
dietary linoleate difference was muted by the relatively long periods 
of incubation with fura-2 before the stimulation with thrombin and 
the taking of aliquots for TX synthesis measurement. However, 
because glucose was provided in the HBS used to suspend the 
platelets, it is unlikely that platelet fatty acids were utilized for 
metabolic energy. Indeed, the lack of difference after the relatively 
long sample preparation time required to do the [Ca++]i analyses using 
fura-2 may be analogous to the lack of dietary linoleate difference 
observed in fasted rat whole blood TX synthesis as compared with 
when the rats had been fed a meal (Sullivan and Mathias, 1982), 
Additionally, thrombin-stimulated TX synthesis by isolated platelets 
suspended in autologous plasma in humans has been shown to be 
unaffected by dietary fat composition as compared with when 
platelets were stimulated with collagen (Manatt et al., 1989), Collagen 
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stimulation of platelet TX synthesis resulted in lower TX synthesis 
when the young women examined in the study of Manatt et al. were 
fed a diet providing moderate amounts of linoleate as compared with 
when less linoleate was fed. This would indicate that milder 
stimulation of platelets, by collagen, rather than with thrombin, 
might have better illustrated the protective effects of moderate 
linoleate consumption in our study. 
In experiment 1, the addition of aspirin, which inhibits the 
enzyme cyclooxygenase, to platelets stimulated with thrombin caused 
a small, but statistically significant, decrease in the rise in [Ca++]i as 
compared with no aspirin. However, the addition of extracelluar 
calcium negated this effect. Because there was no difference in the 
rise in [Ca++]i with the addition of extracellular calcium alone, the 
lower rise in [Ca++]i with aspirin alone Indicates that the action of 
cyclooxygenase products is required for maximal rise in [Ca++]i when 
the only source of calcium is from intracellular stores. A similar 
dependence on cyclooxygenase products for maximal rise in [Ca+'*']i 
when platelets were stimulated by ADP and collagen was 
demonstrated by Rink and Hallam (1984). No apparent decrease in 
the rise of [Ca++]i was observed by Rink and Hallam in aspirin-treated 
platelets stimulated with thrombin. However, Rink and Hallam 
measured the rise in [Ca++]i using the fluorescent calcium indicator 
quin-2, and quin-2 is not particularly sensitive to small changes in 
higher [Ca++]i because it has a high buffering capacity for free 
calcium. This effect also works to dampen large changes in [Ca++]i 
which might be observed. Additionally, workers in this field have 
shown that platelet activity is reduced when the incorporation of 
quin-2 is used to measure [Ca^+li as compared with use of fura-2 for 
this measurement (Rao et al., 1985), Therefore, a small, but 
statistically significant, lower rise in [Ca++]i in thrombin-stimulated 
platelets might not be detectable using quin-2 to measure [Ca++]i, but 
using fura-2, as we have done, this difference was detectable. In light 
of the decreased rise in [Ca++]i observed by Rink and Hallam when less 
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potent agonists were, used to stimulate platelets, the small difference 
in thrombin-stimulated [Ca++]i we observed would not be totally 
unexpected. 
In experiment 2, the treatment with ouabain resulted in the 
highest rise in [Ca++]i. Because ouabain inhibits NKA activity, one 
would expect that an Increase In cytosolic sodium ([Ma+]i) and a 
decreased sodium gradient across the plasma membrane would be the 
result, This, in turn, would inhibit the Na"*" to Ca++ exchanger, and 
result in increased [Ca+'*']i, as seen in the values for [Ca"^"*"]! 4 min after 
thrombin stimulation with ouabain treatment as compared with 
when ouabain was not present. However, the kinetics of the increase, 
as represented by the increase in fura-2 fluorescence, showed a more 
linear rise in [Ca"*"^]! than observed without ouabain. This difference is 
reflected in the decreased [Ca++]i measure for the ouabain treatment 
at 2 min as compared with the 2 min measurement without ouabain 
treatment. This may be a result of the difference in the mechanisms 
involved in the rise of [Ca"*"*"]! when NKA is inhibited, and may reflect 
the high capacity and low affinity of the Na+ to Ca++ exchanger for 
calcium (Rasmussen, 1986a), However, the difference in the kinetics 
of the rise in [Ca++]i we observed might reflect the result of the 
effects of increased [Ma"^]i on the Na"*" to H"*" antiporter. With [Na"^]! 
increased, the Ma+ to H+ antiporter would be stimulated to bring H+ 
into the cell in exchange for Na+. This would result in a decrease in 
cytosolic pH, which could affect the activity of any cell protein, 
including calcium channels which allow calcium to enter the cell. 
Moreover, Ghigo et al, (1988) have shown that increases in cellular pH 
occur with thrombin stimulation of platelets and that Ca++ influx 
proceeds only when this alkalinization occurs. Therefore, the more 
acidic intracellular environment which may have been produced by 
ouabain treatment may have caused the change in the kinetics of the 
rise in [Ca++]i we observed in our experiment. 
Pritchard and Ashley (1986) investigated NKA and the Na+ to 
Ca++ exchanger in isolated smooth muscle cells using fura-2 to 
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measure [Ca^+]i. They found that, with extracellular ionic calcium at 
2.5 mM, ouabain treatment resulted in significantly Increased [Ca++]i 
in these cells, as compared with cells not treated with ouabain. The 
difference between treated and untreated smooth muscle cells was 
greater than we observed with platelets, but the trend was the 
same. The lack of dietary treatment effect on this measure indicates 
that platelet NKA is unaffected by increases in platelet linoleate 
effected by increases in dietary linoleate, This might be considered to 
be analogous to the results of Abeywardena et al, (1984), This group 
found that significant composition and physical (fluidity) changes in 
cardiac sarcolemma effected by increased dietary polyunsaturated fat 
in rats caused no change in the activity of NKA. However, this does 
not correspond to the decrease in NKA in rat thymocytes reported by 
Murray and Patrick (1986), Our results and the results of Murray 
and Patrick do not agree with those of Heagerty et al, (1986), This 
group found that leukocytes had increased NKA activity when the 
diets of human subjects were supplemented with linoleate from 
safflower oil. One would expect that platelets would respond similarly 
to dietary treatment as thymocytes and leukocytes. However, the 
difference between our results and those of the other two groups 
may be in the method we used to detect the action of NKA, because 
our method was a more indirect measure. 
Treatment of platelets with nifedipine resulted in almost 
complete blockage of the rise in [Ca++]i upon stimulation with 
thrombin, It is probable that the concentration of nifedipine used 
(1 iJiM) was high enough to completely block all calcium channels, 
because Mustafa and Askar (1986) reported that 1 ^M nifedipine 
treatment of bovine left anterior descending coronary arteries 
resulted in 100% relaxation. With this result in mind, it seems that 
the apparent lack of increase in [Ca++]i in platelets after stimulation 
with thrombin would be expected. This would also explain the lack of 
dietary linoleate effect in this measure. 
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The pretreatment of platelets with various effectors before 
stimulation with thrombin resulted in significant differences in TX 
synthesis due to the effectors used for the in vitro treatments, In 
experiment 1, pretreatment with 100 piM aspirin significantly 
decreased TX synthesis suggesting that the aspirin treatment 
inhibited cyclooxygenase as would be expected, However, addition of 
extracellular calcium negated this effect significantly, although not 
completely, suggesting that the concentration of aspirin was not high 
enough to completely inhibit cyclooxygenase activity. The highest 
synthesis of TX occurred with the presence of extracellular calcium. 
This is not surprising, because all of the enzymes required in the 
synthesis of TX are stimulated by calcium. However, all of these 
enzymes are located within the cell and the rise in [Ca++]i was not 
found to be affected with this treatment. 
In experiment 2, ouabain treatment resulted in a significant 
increase in TX synthesis which may indicate that [Na+li increases or 
decreases in cellular pH effected by increased [Na+li have an effect 
upon the enzymes required for TX synthesis. The rise in [Ca++]i was 
the highest in this in vitro treatment, and this may have played a 
role in the increased TX synthesis. However, the magnitude of the 
difference in TX synthesis was much greater than the magnitude of 
the difference in [Ca++]i. Nifedipine treatment of platelets before 
stimulation with thrombin resulted in lower TX synthesis, but this 
was not significantly lower than without nifedipine. This is 
unexpected because there was basically no increase in [Ca"*"^]) with this 
treatment. It is possible that a large portion of the TX measured was 
synthesized prior to addition of in vitro effectors and thrombin 
treatment. Unfortunately, aliquots of platelets were not taken before 
stimulation for determination of TX concentration. 
In conclusion, the results of this experiment indicate that 
platelet [Ca++]i is not modified by differences in platelet composition 
caused by feeding differing concentrations of dietary linoleate. The 
effect of [Ca++]i on dietary modification of TX synthesis is unclear, 
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because no differences In TX synthesis due to dietary linoleate were 
found, 
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PAPER IL RAT PLATELET PHOSPHOLIPASE A2 ACTIVITY AND 
THROMBOXANE SYNTHESIS ARE CONCOMITANTLY 
AFFECTED BY DIETARY LINOLEIC ACID 
Abstract 
Platelet thromboxane (TX) synthesis is dependent upon release 
of arachidonic acid from the membrane phospholipid bilayer by 
Phospholipase A2 (PLA). Regulation of TX synthesis may be by 
regulation of PLA which may be affected by the fatty acid (FA) 
composition of the membrane in which PLA resides, Male Sprague-
Dawley rats were fed diets which supplied 30 en% as fat. Dietary fat 
was composed of corn oil and beef tallow to provide 3,0, 4.5, 6,0, 7,5, 
or 9.0 en% linoleate, with cholesterol added to provide equal 
cholesterol in all diets. Rats were fed for 30 days with 8 rats/diet. 
Isolated platelets were assayed for FA composition, net PLA activity, 
and TX synthesis. Liver was analyzed for FA composition. The 
percentage of linoleic acid in platelet and liver FA rose linearly with 
increasing dietary en% linoleic acid. Net PLA activity and TX 
synthesis were correlated; both decreased as linoleate rose from 4.5 to 
9.0 en%. The concomitant changes in platelet FA composition, net PLA 
activity, and TX synthesis suggest that membrane FA composition 
controls net PLA activity and TX synthesis in rat platelets when diets 
provide from 4.5 to 9.0 en% linoleate. Other factors seem to be 
operative at lower linoleate concentrations. 
Introduction 
The observation that increased consumption of polyunsaturated 
fatty acids (PUFA) in proportion to saturated fatty acids is protective 
against cardiovascular disease has been generally accepted by the 
scientific community. However, the cellular mechanism for this 
protective effect is still unclear. Because linoleic acid is the dietary 
precursor of eicosanoids much research has been done to determine 
the effect of Increased PUFA in the diet on eicosanoid synthesis. A 
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cellular mechanism has not been elucidated for the general 
observation that when PUFA consumption is greater than that 
sufficient to alleviate the accumulation of eicosatrienoic acid indicative 
of essential fatty acid deficiency, eicosanoid synthesis first increases, 
and then decreases, as the PUFA concentration of the diet rises to 10 
en% linoleate (Dupont, 1987). It would seem that more than mere 
dietary precursor availability controls eicosanoid production. The 
lower eicosanoid synthesis found with higher (i.e. 5 to 10 en%) linoleate 
consumption is desirable for conservation of essential metabolites. Also 
increased eicosanoid production is generally associated with 
pathological conditions, so it may be postulated that eicosanoid 
metabolism is involved in the protective effects observed with 
increased consumption of PUFA and that research is necessary to 
determine the cellular mechanism for these effects, 
In the platelet, phospholipase Ag (PLA) releases arachidonic acid 
from cellular phospholipids upon cellular activation, The release of 
arachidonic acid is required for the synthesis of thromboxane A2 (TX) 
by cyclooxygenase and thromboxane synthetase and other eicosanoids 
which are an important part of the platelet's response to stimulus. 
All three of the enzymes required for TX synthesis are located in 
platelet membranes (Blllah et al., 1980), 
Kitagawa et al. (1985) demonstrated that changes in membrane 
fluidity produced by in vitro incubation with PUFA Inhibited platelet 
aggregation. Berlin et al. (1980) demonstrated, by feeding several 
different sources of fat to rabbits, that the composition of dietary fat 
affects the composition of platelet membrane phospholipids and 
platelet membrane fluidity, with platelet membrane fluidity rising 
with increasing dietary PUFA content. 
Ballou and Cheung (1983, 1985) reported that potential PLA 
activity in human platelets is higher than previous studies have 
indicated because of the presence of an endogenous inhibitor of its 
activity. Studies assaying platelet microsomal PLA activity in the 
presence of the cell fraction containing the endogenous inhibitor or 
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various lipids indicated that PUFA were the inhibitors of PLA activity 
and that this inhibition was not reversed by excess calcium which is 
also required for the activity of PLA. Therefore, the role of 
membrane fatty acid composition effects on PLA in cellular activation 
and regulation of eicosanoid metabolism may be important, 
Mârki and Franson (1986) observed that in vitro alteration of 
microsomal membranes to increase polyunsaturated fatty acid 
proportion in white blood cells decreased PLA activity. Needleman et 
al. (1982) demonstrated that incubating platelets with linoleic acid to 
increase the linoleic acid content of their phospholipids served to 
decrease thromboxane synthesis. Sato et al. (1987) showed that 
incubation of platelets with linoleic acid, but not other 18 carbon fatty 
acids, interfered with platelet aggregation and the synthesis of TX 
from exogenously added arachidonic acid. The study demonstrated 
that free linoleic acid was intercalated into the platelet membranes 
and that the rise in cytosolic free ionized calcium, required for 
activation of PLA and enzymes required for synthesis of TX, was 
inhibited by the same concentration of linoleic acid which inhibited 
aggregation and TX synthesis, This suggests that the action of free 
linoleic acid upon platelet activation is through interference with the 
receptor-operated calcium channel. However, it is not clear that 
changes effected by in vitro Incubations demonstrate the effects of 
dietary modification of platelet membranes because the effects of the 
fatty acids which were added to these platelet suspensions in vitro 
were, for the most part, eliminated by changing the medium in 
which the platelets were suspended. 
Momchilova et al. (1985) reported that rat liver microsomal PLA 
activity was decreased by feeding a diet high in PUFA (sunflower oil) 
as compared with a diet composed of hydrogenated sunflower oil. 
However, because hydrogenated fats contain many e'/a/?5-lsomers, this 
study may not reflect the effect of consumption of animal fats which 
are the most common source of saturated fats for humans. 
Kawaguchi et al. (1981) found that feeding rabbits excess cholesterol 
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produced no effect on platelet PLA activity, although increased 
synthesis of thromboxane was induced. This indicates that dietary 
cholesterol may effect changes in eicosanoid metabolism independently 
of PLA activity. However, the amount of cholesterol fed in this study 
was extremely high (1% of an otherwise undefined diet); therefore,-this 
study may not reflect changes observed with more normal cholesterol 
consumption, but it does indicate the need for control of cholesterol 
consumption in studies of dietary fatty acid effects on PLA activity to 
eliminate confounding the dietary experimental variables, 
In our study, net PLA activity and TX synthesis were measured 
in platelets from rats fed diets which differed only in fatty acid 
composition with the cholesterol content of all diets held constant. 
Two dietary fat sources, beef tallow and corn oil, were combined in 
five different proportions to formulate diets which would achieve 
different fatty acid profiles in the rat's platelets. We found that as 
dietary en% linoleate was increased the percent platelet linoleate 
increased as well. Both net PLA activity and TX synthesis in these 
platelets were decreased by feeding diets which provided from 4.5 to 
9.0 en% linoleate. Effects with 3.0 en% linoleate were not in the linear 
range and may involve different regulatory mechanisms. 
Materials and Methods 
Animals and diets 
This research was approved by the Iowa State University 
Vertebrate Animal Use Committee. Forty 8-wk-old male Sprague-
Dawley rats were purchased from Amitech (Omaha, NE). When they 
arrived they were housed in a room maintained at 22X and 
approximately 50% humidity, After 2 d of acclimation with feeding of 
Mouse/Rat Diet (6% fat, Teklad, Winfield, lA), they were assigned to 
experimental diets in a randomized block experimental design. The 
blocks represented the days rats were sacrificed and samples were 
processed. 
The experimental nutritionally-complete diets supplied 30 en% as 
fat. The dietary fat was composed of different proportions of corn oil 
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and beef tallow to provide 3.0, 4,5, 6.0, 7.5, or 9.0 en% llnolelc acid, 
with cholesterol added as required to provide equal cholesterol in all 
diets (Table 1). The fatty acid composition of the corn oil and beef 
tallow used to prepare the diets was analyzed. Rats were fed ad 
libitum with 8 rats/diet. Food consumption was determined over a 
48 h period after 3 wk of feeding. Tap water was available ad 
libitum for drinking. Rats were weighed weekly, After 30 d of 
feeding, rats were fasted overnight. Food was returned to the rats 
the next morning to control the postprandial time. Two to three 
hours after food was returned to each rat, the rat was anesthetized 
with ether. Nine milliliters of blood was drawn from an exposed 
jugular vein into a syringe containing 1 ml acid citrate dextrose 
anticoagulant (4,5 g% sodium citrate, 2,7 g% citric acid (monohydrate), 
3.6 g^ dextrose). The rats were then killed by exsanguination by 
severing the aortic artery. The liver was then excised, a 0.5 g 
sample placed in 5 ml pH 7,4 50 mM Phosphate buffer, and 
homogenized with 10 passes of a Potter-Elvejhem homogenlzer, A 0.5 
ml aliquot of the liver homogenate was frozen on dry ice and stored 
at -80*C for later fatty acid analysis. 
Platelet preparation 
Platelets were Isolated and washed as described previously 
(Krumhardt, 1989a). The washed platelets were resuspended in 
TRlS/NaCl Buffer (120mM NaCl, 30mM TRIS-HCl, pH 7.5) resulting in a 
platelet suspension containing approximately 2 X 10^ cells/ml. 
Fatty acid analysis 
A 1 ml aliquot of the washed platelets in TRlS/NaCl Buffer was 
frozen on dry ice for later fatty acid analysis. Fatty acid analysis 
was performed essentially as described previously (Krumhardt, 1989a), 
Liver total fatty acids were saponified in the same manner as 
described for platelets in tubes containing 0.2 ml of the liver 
homogenate, 0.3 ml water, 0.4 ml 50% aqueous KOH (w/v), and 1.1 ml 
ethanol. The tubes were incubated in a water bath at 60*C for 60 
min. All other steps of the liver fatty acid methyl ester preparation 
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Table 1. Composition of Experimental Diets 
Energy Percentage Linoleate 
Ingredient 3.0 4.5 6^0 Z3. 9.0 
g/lQQg 
Beef Tallow & 13.70 12.20 10.80 9.20 7.80 
Corn Oilb 0.60 2,10 3,50 5.10 6.50 
Casein c 22.35 22,35 22,35 22.35 22,35 
Sucrose b 26.43 26.43 26.43 26.43 26.43 
Corn Starch ^  26.43 26,43 26.43 26.43 26.43 
Cellulose d 5,03 5.03 5.03 5.03 5.03 
AIN Mineral Mixture 76® 3,93 3.93 3.93 3.93 3.93 
AIN Vitamin Mixture 76® 1.11 1.11 1.11 1.11 1.11 
L-Methionine c 0,33 0.33 0.33 0.33 0.33 
Choline Chloride ^  0.08 0.08 0.08 0.08 0.08 
Ascorbic Acid (antioxidant) f 0,01 0.01 0.01 0.01 0.01 
Cholesterol (mK/100K)f 0,00 1,60 3,16 4.90 6.40 
^Meat Lab., Department of Animal Science, Iowa State 
University. 
^lowa State University Food Stores: Mazola Corn Oil, Crystal 
Sugar, and Argo Corn Starch. 
^United States Biochemical Co., Cleveland, OH. 
^Teklad, Madison, WI. 
^Composition described by the AIM Ad Hoc Committee on 
Standards for Nutritional Studies (1977). ICN Nutritional Biochemicals, 
Cleveland, OH, 
^Sigma Chemical Co., St. Louis, MO, 
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were the same as for platelet fatty acid analysis, Fatty acid methyl 
esters were analyzed by gas chromatography using a Varian 3700 gas 
chromatograph (Walnut Creek, CA) as previously described 
(Krumhardt, 1989a). 
PhosDholipase A2 activity 
Net platelet phospholipase A2 (PLA) activity was assayed by 
using a modification of the procedure of Ballou and Cheung (1983). A 
450 nl aliquot of the washed platelets in pH 7.5 TRIS/NaCl Buffer was 
incubated at 37*C with 50 ^1 of substrate which contained 
approximately 0,03 ^Ci of 1- Palmitoyl-2-[l-l^C] arachidonyl-a/?-
glycerol-3-phosphatidyl choline, specific activity 54.9 mCi/mmol, (New 
England Nuclear, Boston, MA) in substrate buffer containing 50 mM 
taurocholic acid, 20 mM calcium chloride, and 0,05 g% fatty acid free 
bovine serum albumin. Taurocholic acid was used as a biological 
amphipath in the assay to aid in delivery of substrate to the PLA 
enzyme. The concentration used was the same as found in human 
serum (Dupont et al,, 1988). The calcium chloride addition served to 
stimulate platelet activity. At substrate addition and after 40 
minutes incubation, 100 pi aliquots of the reaction mixture were 
added to 100 (jil of 100% ethanol containing 2% glacial acetic acid and 
330 nM arachidonic acid (to serve as a carrier in the thin-layer 
chromatography separation described below), [l-l'^C] arachidonic acid 
released in each aliquot was separated from labeled substrate by 
using thin-layer chromatography on 250 pm silica gel G plates (Fisher 
Scientific) with ethyl acetate: acetic acid (99:1, v/v) as the solvent 
system. Bands of the silica gel corresponding with arachidonic acid 
(Nu-Chek-Prep, Inc., Elysian, MN) and phosphatidyl choline (Sigma 
Chemical Co,) were scraped into scintillation vials; 8 ml Bioscintiverse 
BD (Fisher Scientific) was added; and radioactivity was determined by 
liquid scintillation counting in a Packard Tri-Carb Liquid Scintillation 
Spectrophotometer (Model C2425, Packard Instruments, Downers 
Grove, IL) using the external standards ratio method to correct for 
quenching and to calculate dpm of radioactivity in the sample. The 
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phosphatidyl choline used to determine the migration of phosphatidyl 
choline in the thin layer chromatography separation system appeared 
to contain arachidonic acid indicating contamination with 
phospholipase A2. This contamination was also observed by Filgueiras 
and Possmayer (1987). Blank tubes containing buffer and substrate, 
but no cells, had no release of [l-l'^C] arachidonic acid during the same 
time period. All steps of the PLA assay were performed using 
polypropylene test tubes. 
Tests performed with platelets suspended in pH 7.0 and pH 8,0 
TRIS/NaCl buffers demonstrated that net PLA activity was higher at 
pH 8.0, but not significantly higher than activity at pH 7.5 (data no 
shown). Net PLA activity was significantly lower when platelets were 
suspended in pH 7.0 buffer. The pH 7.5 TRIS/NaCl buffer was chosen 
for the assay because it reflects a more physiological pH than pH 8.0, 
and better mimics in vivo conditions. The 40 min incubation time 
was selected to achieve maximum net PLA activity in the least time. 
The time course of the assay may be seen in Figure 1. The time 
course was done by taking aliquots of the PLA assay mixture as 
described at 0, 10, 20, 30, 40, 50, and 60 min (Figure 1). 
Thromboxane Bo synthesis 
At the same time points as for the PLA assay, 100 pi aliquots of 
the PLA reaction mixture were added to 20 [il of 42 mM aspirin in 
saline to stop TX synthesis and the samples were frozen on dry ice 
and stored at -20®C. Double antibody radioimmunoassay of TX using 
^H-TX (New England Nuclear, Boston, MA) to competitively bind 
antibody was performed as described previously (McCosh et al., 1976 
and Steinberg et al., 1982), with dual channel counting used to correct 
for the activity in the samples. The TX antiserum had a cross-
reactivity with 6-keto prostaglandin Fia of 20%. No correction was 
made for this cross reactivity. The concentration of I'^C-TX in these 
samples was too small to determine the amount of I'^C-TX 
synthesized from the PLA assay substrate, so only endogenously 
derived TX was determined. TX synthesis was parallel to net PLA 
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Figure 1. Time course of the release of [1-^'^C] arachidonic 
acid from 1- Palmitoyl-2-[l-J'^C] arachidonyl-5/7-
gIycerol-3-phosphatidyl choline 
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activity as may be seen by observation of the time course of the 
assay done by taking aliquots of the PLA assay mixture as described 
at 0, 10, 20, 30, 40, 50, and 60 min for TX analyses (Figure 2), 
Protein analysis 
All of the platelet suspension remaining after use for other 
analyses was frozen on dry ice and stored at -20°C for later protein 
analysis which was performed by using the procedure of Lowry et al, 
(1951). Fatty acid-free bovine serum albumen fraction V (Sigma 
Chemical Co., St. Louis, MO) was used as the protein standard, 
gtatistkail mgthQfls 
All analyses were done in duplicate for each sample. Statistical 
analyses were done using the General Linear Model, Least Squares 
Means, and Pearson Correlation Coefficients procedures of Statistical 
Analysis System, version 5.16, Cary, N.C. 
Results 
Animals and diets 
The data for rat weight gain and food consumption are shown 
in Table 2. There was no difference in the growth rate of rats fed 
different diets (range = 3.5 to 6.5 g/d, pooled SEM = 0.5). There was 
no significant difference in food consumption due to diet (range =16,5 
to 23,0 g/d, pooled SEM = 0,2). There were no signs of essential fatty 
acid deficiency in any animals. 
Fatty acids 
The results of platelet total fatty acid analysis are shown in 
Table 3. The percent linoleic acid in platelets increased with 
increasing concentrations of dietary linoleate, resulting in an excellent 
correlation between the two (r = 0.873, P< 0.0001). Concurrently, the 
percent oleic acid in platelets decreased with increasing concentrations 
of dietary linoleate (r = -0.829, P < 0.0001). 
The results of liver total fatty acid analysis are shown in 
Table 4, The percent linoleic acid in liver increased with increasing 
concentrations of dietary linoleate, providing an excellent correlation 
between the diet and liver linoleic acid (r = 0,937, P < 0,0001), 
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Figure 2. Time course of thromboxane A2 synthesis measured 
at the same time as phospholipase Â2 activity 
(measured as the thromboxane A2 metabolite, 
thromboxane 82 ) 
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Table 2. Food consumption and weight gain of rats fed diets 
with different linoleate concentrations 
en% Linoleate n 
Weight gain^ 
(k/30 davs) 
Food consumption^ 
(s/dav) 
3.0 8 4.5±0.2 20.5±0.5 
4.5 8 4.6±0,2 20.6±0.5 
6.0 8 3.9+0.2 19.0±0.5 
7.5 8 4.3±0,2 19.8±0.5 
9,0 8 4.4±0,2 19.7+0.5 
^Values are means ± SEM as determined by least squares means. 
No significant difference due to dietary treatment in either measure 
was determined by the general linear model analysis of variance. 
Table 3 Platelet total fatty acids of rats fed experimental diets 
Fatty acid *C:*double bonds 
Dietary linoleic acid 12:0 14:0 16:0 16:1 18:0 18:1* 18:2* 18:3 20:4 
en % n % of total fattv acidsl 
3.0 8 0.29 0.84 35.67 0.25 17.82 15.12^ 4.25a 0.53 25.24 
4.5 8 0.33 1.07 35.81 0.67 18.05 13.9ia 5.17b 0.77 24.23 
6.0 8 0.22 0.89 36.89 0.56 18.04 12.72b 5.95c 0.53 24.21 
7.5 8 0.14 0.82 35.76 0.55 18.85 11.6lb 6.65d 0.47 25.15 
9.0 8 0.22 0.83 36.19 0.37 18.80 11.49b 6.966 0.43 24.68 
Pooled SEM 0.08 0.15 0.49 0.16 0.39 0.34 0.19 0.12 0.92 
1 Values are means in each dietary group. Means with the same superscript 
letter or no superscript letter are not significantly different at the 0.05 confidence 
level as analyzed by least squares means. 
* Values are significant at p < 0.0001. 
Table 4. Liver total fatty acids of rats fed experimental diets 
Fatty acid #C;*double bonds 
Dietary linoleic acid 12:0 14:0 16:0 16:1 18:0* 18:1** 18:2** 18:5 20:4 22:6* 
en% n % of total fattv acids^ 
3.0 8 0.63 0.27 20.20 3.24 14.43^ 26.20^ 7.97^ 0.18 20.90 5.98^ 
4.5 8 0.69 0.28 21.40 3.84 11.08^ 30.76^ 11.33^ 0.13 17.23 3.26^ 
6.0 8 0.62 0.22 20.49 3.00 12.20ab 25.92^ 15.11^ 0.20 18.85 3.40^ 
7.5 8 0.56 0.21 20.37 2.68 12.45^^ 23.25^0 17.46^ 0.17 19.56 3.29^ 
9.0 8 0.55 0.18 20.03 3.35 12.26ab 21.35^0 19.54® 0.19 19.33 3.22^ 
Pooled SEM 0.06 0.03 0.37 0.45 0.61 0.99 0.42 0.02 0.94 0.58 
lvalues are means. Means with the same superscript letter or no superscript 
letter are not significantly different at the 0.05 confidence level as analyzed by least 
squares means. 
* Values are significant at p < 0.01 
**Values are significant at p < 0.0001 
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Concurrently, the percent oleic acid in liver decreased with increased 
dietary linoleate (r = -0,558, P < 0.0002). The percent stearic acid in 
liver was also decreased by increasing dietary linoleate, however the 
correlation or these two variables was not significant. The 3 en% 
linoleate diet-fed rats had a significantly higher percentage of 
docosahexaenoic acid (22:6) in liver as compared with those fed any 
other diet. 
There were positive correlations between platelet linoleate and 
liver linoleate (r = 0.938, P < 0,0001), and between platelet oleate and 
liver oleate (r = 0,589, P < 0.0001), indicating that platelet linoleate 
and oleate reflect the fatty acid composition of liver. 
The effects of increasing the percentage of dietary linoleate on 
platelet net PLA activity and TX synthesis are shown in Table 5. 
Platelet net PLA activity was greatest for rats fed the 3.0 and 4.5 en% 
linoleate diets. There was a strong negative correlation between net 
PLA activity and percentage of dietary linoleate (r = -0.66, P < 0,0001); 
demonstrating an inhibitory relationship of dietary linoleate to net 
PLA activity. However, the trend may be toward a lower net PLA 
activity with dietary linoleate less than 4.5 en%, suggesting a 
quadratic function. 
Platelet TX synthesis was greatest for the rats fed the 4.5 en% 
linoleate diet. When the 3.0 en% linoleate diet was fed, platelet TX 
synthesis was lower than when the 4.5 en% linoleate diet was fed. A 
similar relationship to that of net PLA activity and dietary linoleate 
is illustrated by the moderate negative correlation between TX 
synthesis and dietary linoleate (r = -0,459, P < 0,003), The 
relationship between dietary linoleate and TX synthesis is much 
stronger when the data for rats fed the 3,0 en$ linoleate diet are 
omitted (r = -0,740, P< 0.0001). There was a trend for a quadratic 
relationship between dietary linoleate and TX synthesis (/'< 0.08) as 
might be inferred by the stronger correlation when the data for the 
rats fed the 3.0 en% linoleate diets are omitted. 
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Table 5. Phospholipase A activity and thromboxane 
synthesis in platelets of rats fed experimental diets 
en% Llnoleate n PLA activity^ TX synthesis^ 
3.0 
4.5 
6,0 
7.5 
9.0 
8 
8 
8 
8 
8 
479±38a 
526±38^ 
358+38^ 
276±38b 
271±38b 
37,2±3.5a 
53.1±3.5b 
37.5±3,5â 
29.6±3.5a 
27.8±3,5a 
Values are means ± SEM as determined by least squares 
means. Units are pmol [l-l'^C] arachidonic acid released from 1-
Palmitoyl-2-[l-l'^C] arachidonyl-wW-^lycerol-S-phosphatidyl choline in 40 
min per mg platelet protein. Values with different superscript letters 
are significantly different at P< 0.05 as determined by least squares 
means. 
^Values are means ± SEM as determined by least squares 
means. Units are pmol thromboxane A2 synthesized in 40 minutes 
per mg platelet protein (measured as the metabolite, thromboxane Bg ) 
Values with different superscript letters are significantly different at 
P< 0.05 as determined by least squares means. 
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For all diets, net PLA activity and TX synthesis were correlated 
(r = 0.508, P < 0.0008). This relationship is shown in Figure 3. The 
correlation between net PLA activity and TX synthesis was even 
stronger when the data for rats fed the 3,0 en% linoleate diet were 
omitted (r = 0.61, />< 0.0002). 
Discussion 
FMty 
The changes in platelet total fatty acid composition caused by 
diet followed the same trends which have been demonstrated by 
Berlin et al. (1980) and those found previously in our laboratory 
(Krumhardt, 1989a). These changes are significantly different due to 
dietary fat only for the proportion of oleic and linoleic acids of the 
total fatty acids. Because the liver is the organ which most centrally 
controls lipid metabolism, it is interesting to note that liver fatty acid 
profiles show the same trends as platelets, and that liver fatty acids 
are strongly correlated with platelet fatty acids. This would indicate 
that the proportion of oleic and linoleic acids of platelet total fatty 
acids might be useful as an indicator of dietary fatty acid composition 
and of the composition of other organs as well. 
PhosDholipase Ao and thromboxane 
Because linoleic acid is the dietary essential fatty acid precursor 
of the thromboxane precursor, arachidonic acid, it has sometimes 
been assumed that dietary linoleic acid affects TX synthesis by 
controlling the amount of substrate available, However, platelet total 
fatty acid composition shows that the arachidonic acid concentration 
in platelets is unchanged by changes in the linoleic acid content of 
diet. This indicates that the total substrate pool is not the entity 
which controls the amount of arachidonic acid released by PLA for 
the eventual synthesis of TX. Indeed, as shown in Table 5, the 
absolute amount of arachidonic acid released from radiolabeled 
phosphatidyl choline is ten-fold greater than the absolute amount of 
TX synthesized at the same time. When considered in view of the 
metabolism of the whole platelet, it is obvious that even more than a 
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arachidonyl-572-glycerol-3-phosphatidyl choline in 40 minutes per mg 
platelet protein, 
bpmol thromboxane Ag synthesized in 40 minutes per mg 
platelet protein (measured as the metabolite, thromboxane 62 ). 
Figure 3. Platelet phospholipase A2 activity (PLA) is 
correlated with thromboxane (TX) synthesis 
(r = 0.508, P< 0.0008) 
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ten-fold difference between the amount of arachldonlc acid released 
and TX synthesis would be found because the radiolabeled 
phosphatidyl choline substrate represents only part of the substrate 
pool for the action of PL A. This shows that only a small fraction of 
arachldonlc acid released from cellular phospholipids by PLA is 
converted to TX. In fact, the amount of l^C-TX synthesized from l^C-
labeled phosphatidyl choline used as the substrate for determination 
of net PLA activity was too small to determine. Such a ratio of 
substrate to product might suggest that control of net PLA activity, 
by any mechanism, has no bearing upon the ultimate synthesis of TX 
in the same system. 
However, the highly significant correlation between net PLA 
activity and TX synthesis, which are both significantly affected by 
diet, indicates otherwise, PLA and the enzymes involved in synthesis 
of TX, cyclooxygenase, and thromboxane synthetase, are all enzymes 
which reside in the cell membrane. The results of this experiment 
indicate it is probable that all of these enzymes are, at least in part, 
regulated by the fatty acid composition of the phospholipid bilayer in 
which they reside, not by substrate availability. Ballou and Cheung 
(1983, 1985) have demonstrated that micromolar concentration of free 
polyunsaturated fatty acids inhibit the activity of semi-purified PLA. 
Additionally, increases in the PUFA content of microsomal membrane 
preparations of white blood cells (Màrki and Franson, 1986) and liver 
(Momichilova et al., 1985), produced by in vitro manipulations, also 
have been shown to result in a decrease in PLA activity. Our results 
indicate that dietary modification of membrane fatty acid composition 
affects both net PLA activity and TX synthesis, especially in the range 
of 4.5 to 9.0 enSg dietary linoleate. An inhibitory relationship was 
evident with 4.5 to 9.0 en% dietary linoleate, but the values with less 
than 4,5 en% linoleate are suggestive of other effects. The dietary 
effect due to feeding the 3.0 en% linoleate diet may be different from 
the effects observed with feeding diets providing from 4.5 to 9.0 en^ 
linoleate. When linoleate provides 3.0% of energy, factors other than 
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diet Induced platelet fatty acid composition changes may influence 
platelet TX synthesis, but the factors which cause this effect cannot 
be deduced from this experiment. The quadratic tendencies suggested 
by these data indicate a complex relationship between dietary 
linoleate, platelet net PL A activity, and platelet TX synthesis. 
However, the data presented here would indicate that, in the rat, 
changes in membrane composition induced by diet provide an altered 
environment for the membrane embedded enzymes involved in the 
synthesis of TX which could provide a cellular mechanism for the 
protective effects associated with moderate consumption of 
polyunsaturated fatty acids. 
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PAPER III. DIETARY FAT EFFECTS ON HUMAN PLATELET 
FATTY ACID COMPOSITION, CYTOSOLIC CALCIUM, 
PHOSPHOLIPASE Ag ACTIVITY, AND THROMBOXANE SYNTHESIS 
Abstract 
Studies using rats fed diets different in fatty acid (FA) 
composition have shown that platelet FA is dependent on dietary FA. 
In rats, platelet FA affects net phospholipase A2 activity (PLA) and 
thromboxane synthesis (TX), but not cytosolic calcium. This study 
was done to determine if the same relationships exist in humans. 
Males, 20-34 years old, consuming self-selected diets including strict 
vegetarian, ovolacto-vegetarian, and diets including meat, were 
examined for their usual dietary fat composition and content using 
three 24-hour food intake records. Isolated platelets were assayed for 
total FA composition, cytosolic calcium, net PLA, and TX. Plasma total 
lipid FA was determined. Data were grouped by reported linoleate 
intake into low (2.5-5.0 en%, LL), medium (>5.0-8.0 en%), ML, and high 
(>8.0-11.1 en%, HL) linoleate intake groups. The LL group had lower 
platelet linoleate percentages as compared with ML and HL groups, 
which were not statistically different, Platelet linoleate was 
correlated with dietary linoleate from 2.5-8.0 en% linoleate; there was 
no correlation of the same measures when dietary linoleate was 
greater than 8.0 en%. Plasma linoleate concentration rose with 
dietary linoleate. No differences due to dietary linoleate in cytosolic 
calcium or net PLA were found. Platelet TX was lowest in the ML 
group. Net PLA and TX were lower than in rat platelets, although a 
correlation between the two was found. The data suggest that 
regulation of PLA and TX in humans is different from that in rats. 
Medium linoleate intake (5.0-8.0 en%) is recommended to promote 
lower platelet TX in humans. 
Introduction 
Major cardiovascular diseases account for over one-third of 
deaths in the United States (National Center for Health Statistics, 
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1988), Blood platelets have been implicated in the progression of 
development of atherosclerotic lesions (Ross and Glomset, 1976). 
Because lower intakes of saturated fat and higher intakes of 
polyunsaturated fat have been shown to be associated with lower 
incidence of these diseases (Carroll et al, 1983), much research has 
been done to determine the mechanisms of these effects. This paper 
presents the effects of dietary fat composition on some functions of 
platelets in a small sample of free-living males consuming self-selected 
diets, The subjects in this study were recruited to include persons 
consuming no animal products (vegans), persons consuming no meat 
or fish products (ovolactovegetarians, OLV), and persons who do 
include meat and fish products as part of their usual diet (omnivores, 
OMNI), It was expected that inclusion of persons from these three 
groups would provide a wide range in the percentage of energy (en%) 
from fat and a variety of fat compositions. Isolated blood platelets 
from these subjects were assayed for their fatty acid composition, 
cytosolic calcium, net phospholipase A2 activity (PLA), and 
thromboxane As (TX) synthesis to determine the effect of dietary fat 
upon these measures. The fatty acid composition of blood plasma was 
also measured. 
Platelet fatty acid composition may be changed by changes in 
the composition of dietary fat in both experimental animals and in 
man (Davenas et al,, 1984 and Renaud et al., 1986). This, in turn, 
affects the activity of platelets. When platelet composition is modified 
in vitro to eliminate any differences in intestinal absorption and 
whole body metabolism, similar effects may be seen (Needleman et 
al., 1982). However, a year long study of men and women indicated 
that the relationship between dietary fat intake and plasma fatty 
acid composition is confounded by the age and sex of subjects (Reeves 
et al., 1984). This study was done, in part, to determine if platelet 
fatty acid composition is more indicative of composition of dietary fat 
than plasma fatty acid composition. 
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The activity of platelets Is regulated by control of cytosolic 
calcium, A review of cytosolic calcium metabolism is presented in a 
series of two articles by Howard Rasmussen (1986a and 1986b), An 
abbreviated illustration of cytosolic calcium metabolism is shown in 
Figure 1. In brief, when platelets are stimulated by the binding of an 
appropriate messenger to a cell surface receptor, activation of 
phospholipase C ensues. The production of inositol trisphosphate by 
this enzyme results in a rise in cytosolic calcium. The rise in 
cytosolic calcium serves to activate platelet enzymes required for the 
platelet's response to a stimulus. Aberrations in the regulation of 
cytosolic calcium have been associated with hypertension, an 
important factor in some cardiovascular disease. Erne et al. (1984a 
and 1984b) found that increased platelet resting cytosolic calcium was 
correlated with increases in both systolic and diastolic blood pressure 
in human patients, and, that drugs that reduce blood pressure also 
induce a decrease in the levels of platelet resting cytosolic calcium. In 
our laboratory we have found that increasing dietary linoleate from 
3.0 to 7.5 en% effected no changes in regulation of cytosolic calcium in 
rats. The results reported in this paper indicate that, in humans, as 
well as rats, resting platelet cytosolic calcium is unaffected by dietary 
fat composition. 
Increased cytosolic calcium, resulting from activation of 
phospholipase C, stimulates many platelet enzymes, including 
phospholipase Ag, cyclooxygenase, and thromboxane synthetase. All 
of these enzymes reside in cell membranes, and the activity of all of 
these enzymes is required for the synthesis of the potent eicosanoid 
vasoconstrictor, TX (Majerus et al,, 1985), TX is the predominant 
eicosanoid synthesized by platelets, and its effects are autocoid, as 
well as paracrine, in nature. That is, platelets themselves, are 
activated by TX as well as vascular smooth muscle cells. However, 
the effects of TX are confined to the area of synthesis, because 
thromboxane As is spontaneously degraded to its inactive metabolite, 
thromboxane B2, very rapidly. However, increased transcardiac 
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Figure 1. Stimulus response coupling in platelets 
A messenger (hormones, etc,) binds a platelet plasma 
membrane receptor activating phospholipase C through 
the regulatory action of a GTP binding protein, 
Phospholipase C cleaves phosphotidyl inositol 4,5-bis 
phosphate forming the second messengers inositol 
trlsphosphate (IP3) and dlacylglycerol (DG), DG is required 
for secretion. IP3 formed causes the release of free ionized 
calcium from Intracellular storage compartments and 
Influx of calcium from outside the cell. The increase in 
cytosolic free ionized calcium activates many cell proteins, 
including phospholipase C and phospholipase A2 (PL A). PL A 
releases arachidonic acid from cell membrane 
phospholipids. The freed arachidonic acid may be acted 
upon by the enzymes cyclooxygenase and thromboxane 
synthetase (not shown) to synthesize eicosanoids including 
thromboxane A2, a potent vasoconstrictor and platelet 
activator (Rasmussen, 1986a and 1986b). 
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synthesis of TX by platelets has been associated with recent episodes 
of angina pectoris (Hlrsh et al, 1981), This gives credence to the 
hypothesis that platelet elcosanoid synthesis is involved in 
cardiovascular disease. 
Dietary fat modification of platelet fatty acids affects the 
synthesis of TX, although the mechanism for the effects of various 
alterations in dietary fatty acid composition upon platelet activity 
and TX synthesis are still unclear (Mathias and Dupont, 1985), 
Depending on the dietary fatty acid composition and the percentage of 
total fat, TX synthesis may be decreased or unaffected by increased 
polyunsaturated fat. Sullivan and Mathias (1982) found that, in rats, 
feeding a diet providing linoleate sufficient to prevent essential fatty 
acid deficiency (2 en%) resulted in higher TX synthesis as compared 
with when 10 en% linoleate was fed, A similar inverse relationship of 
dietary linoleate to TX in experimental animals has been found by 
others, as well (Hamelin and Chan, 1983), However, other researchers 
have found the opposite relationship (Croft et al., 1984). These 
contradicting results may be due to the different sources of dietary 
fat fed by these researchers or to wide differences in fatty acid 
composition, but this is still not clear. However, lowered TX synthesis 
should be associated with decreased platelet activity; and decreased 
platelet activity has been effected by consumption of relatively less 
saturated and more polyunsaturated fat in humans (Renaud et al., 
1986), 
Decreased platelet activity could be the result of modification of 
membrane fluidity which might change the activity of membrane 
embedded enzymes. Because the activity of PLA is required to free 
arachidonic acid from cell membrane phospholipids for TX synthesis 
by cyclooxygenase and TX synthetase, the activity of PLA may 
control the synthesis of TX, Ballou and Cheung (1985) found that 
human platelets have an endogenous inhibitor of PLA activity and 
that the inhibitor was composed of polyunsaturated fatty acids, This 
might indicate that increases in the polyunsaturated fatty acid 
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composition of platelets caused by different dietary fat composition 
might effect inhibition of PL A. Indeed, Momchilova et al. (1985) found 
that feeding rats a diet high in polyunsaturated fat resulted in 
decreased liver PL A activity. This might indicate that the mechanism 
by which increased polyunsaturated fat in proportion to saturated fat 
(P/S ratio) in the diet is generally associated with decreased TX 
synthesis in the range of 2 to 10 en% linoleate. In our laboratory, we 
have found that feeding rats diets with 4.5 to 9,0 en% linoleate effects 
a linear decrease in net PLA activity and TX synthesis (Krumhardt, 
1989b). The research results reported herein, however, do not indicate 
that this is the case in humans. Platelet net PLA activity was 
unaffected by dietary linoleate. However, significantly lower platelet 
TX synthesis was found when dietary linoleate provided between 5 
and 8 percent of Kcal. Greater platelet TX synthesis was associated 
with diets providing less than 5 en% linoleate or greater than 8 en% 
linoleate. Therefore, linoleate intake between 5 and 8 percent of total 
energy is recommended to promote lower platelet TX synthesis. 
Materials and Methods 
This project was approved by the Iowa State University Human 
Subjects Review Committee. All subjects provided informed consent. 
Sub jects and diets 
Normo-tensive, healthy males between 20 and 34 years of age, 
of normal body weight and Caucasian race, consuming self-selected 
diets, including vegans (n = 3), OLV (n = 9), and OMNI (n = 11), were 
examined for their normal dietary fat composition and percent of 
energy using three 24-hour food intake records which involved the 
recording of all foods and beverages consumed by the subjects for two 
week days and one Saturday. The subjects selected the days to 
record their intake which they felt best reflected their usual diet. 
These records were used to estimate the grams of each food reported 
and the nutrients contained in the subjects' diets were calculated 
using a data base compiled as a Statistical Analysis System database 
on the Iowa State University Computation Center NAS/6 computer. 
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(This database was derived from the USDA Handbook 8 Composition of 
Foods (USDA, 1979), as described by Mertz and Kelsay (1984), and 
obtained from Mary Marshall at the USDA in Beltsville, MD.) This 
database contains nutrient data on the basis of grams nutrient per 
100 grams of edible portion of food, The grams of food for individual 
foodstuffs reported by subjects were estimated using the grams of 
food given for volumes of foods or average servings using USDA Home 
and Garden Bulletin No. 72: Nutritive Value of Foods (USDA, 1981). For 
example, the weight listing for a carrot was 72 g and the weight 
listing for a cup of mashed potatoes was 210 g; these values were used 
as weights for subject intake for one carrot and 1 cup of mashed 
potatoes. The mean daily nutrient consumption for all subjects of all 
nutrients in the database were determined by averaging the three 
days' records for each subject. Diet content of nutrients for which 
the data in this database are incomplete (zinc, magnesium, 
manganese, pantothenic acid, vitamin Be, folic acid, vitamin B12, and 
a-tocopherol) were not calculated, Calculations of the percent of Kcal 
(en%) as protein, carbohydrate, total fat, and linoleic acid were 
determined. The physiological values of 4 Kcal/g for dietary protein 
and carbohydrate, and 9 Kcal/g for dietary fat (Merrill and Watt, 
1955), were used to convert grams to Kcal from each of these dietary 
components. Finally, the percent of total Kcal from each of these 
components was calculated. Some foods in the database did not have 
values for saturated fat, monounsaturated fat, and polyunsaturated 
fat, therefore, the en% provided by each were estimated by 
calculating the proportion of the total of each in grams and 
multiplying these proportions by the percentage of energy as fat. 
The average dietary polyunsaturated/saturated fat ratio (P/S ratio) 
was determined by dividing the average daily grams of 
polyunsaturated fat by the average daily grams of saturated fat. 
The subjects also completed a short questionnaire which 
required the subject to estimate his frequency of consumption of 
dairy products, eggs, fish, poultry, red meats, and organ meats. This 
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questionnaire determined the diet habit group of each subject, 
Vegans had consumed no animal products for at least 6 months. OLV 
had consumed no meat or fish products for at least 6 months. OMNI 
were those subjects not fitting the qualifications for either other diet 
habit group. The questionnaire also established the nutritional 
supplement intake of subjects. These data were used to determine 
the total average daily nutrient intake for each subject. 
After each subject had completed the informed consent forms, 
the 24-hour food intake records, and the diet questionnaires, a 14 ml 
blood sample was drawn by the principal investigator, Barbara 
Krumhardt, a registered Medical Technologist (M,T,(ASCP), registry 
number: 129364), at the Iowa State University Student Health Center 
laboratory. The sample was collected by venipuncture, using aseptic 
technique to prevent transmission of communicable disease, into a 
20 ml sterile plastic disposable syringe containing 1 ml filter-sterilized 
acid citrate dextrose anticoagulant (7,0 g% sodium citrate, 4,2 g^ citric 
acid (monohydrate), and 5,6 g^ dextrose). All samples were collected 
in the morning, one to two hours after the subject had consumed 
breakfast. All subjects had abstained from the use of analgesic drugs 
for at least 10 days prior to blood sample collection. 
Before the blood-sample-collection subject weight, height, and 
blood pressure were measured. Weights and heights were measured 
to assure that all subjects were of normal weight for height. The 
Body Mass Index (BMI) was determined for each subject according to 
the formula BMI = weight/(height)2 (Watson et al,, 1979). Blood 
pressures were determined to assure that subjects had blood 
pressures that were not below 100 mm Hg systolic and 60 mm Hg 
diastolic, or, above 140 mm Hg systolic and 90 mm Hg diastolic. Blood 
pressures were measured using a mercury sphygmomanometer and a 
blood pressure cuff provided by the Iowa State University Student 
Health Center. All subjects had blood pressures within these ranges, 
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PlatQlgt prQpqratjjQn 
Platelets were isolated from anticoagulated blood by 
centrifugation using a modification of the procedure of Hallam et al, 
(1984), Anticoagulated blood in polypropylene tubes was first 
centrifuged at 225 X ^for 5 min. The supernatant platelet-rich 
plasma (PRP) was recentrifuged at 225 X ^for 5 min to remove 
contaminating red and white blood cells. The PRP was then 
centrifuged at 400 X ^for 20 min to sediment the platelets. The 
plasma was removed, and frozen for fatty acid analysis. The tube 
was further drained by blotting on absorbent paper to remove all 
plasma and 3.0 ml of TRIS/NaCl Buffer (120mM NaCl, 30mM TRIS-HCl, 
pH 7.5) was added. The platelets were resuspended by gentle 
vortexing resulting in a platelet suspension containing approximately 
2 X 10^ cells/ml. Two 0,5 ml aliquots were transferred to separate 
tubes for cytosolic calcium and fatty acid analyses, The remaining 
2,0 ml of platelet suspension was left in the same tube. In all tubes, 
the platelets were resedimented by centrifugation at 400 X g for 20 • 
min. The TRIS/NaCl Buffer was decanted, excess buffer was removed 
by blotting on absorbent paper, and the platelets were resuspended, 
by gentle vortexing, for the various analyses. For fatty acid 
analyses, the platelets were resuspended in 1 ml TRIS/NaCl 
(approximately 1 X 10^ cells/ml) and frozen on dry ice for the analysis 
which was done later. For cytosolic calcium analyses, the platelets 
were resuspended in 1 ml HEPES buffered saline (HBS) (145 mM NaCl, 5 
mM KCl, 1 mM Magnesium Sulfate, 10 mM HEPES, 10 mM glucose, pH 
7,4) (approximately 1 X 10^ cells/ml). For PLA assays, the platelets 
were resuspended in 0,8 ml TRIS/NaCl (approximately 4 X 10^ 
cells/ml). The purity of platelet suspensions prepared by this method 
was determined by microscopic observation of smears of PRP stained 
with Wright's stain (Fisher Scientific, Silver Spring, MD). At least 98% 
of cells observed were platelets. 
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Fatty acid analysis 
Fatty acid analyses were performed as described previously 
(Krumhardt, 1989a). Plasma fatty acids were analyzed by gas 
chromatography using the same procedure as for platelet fatty acids, 
substituting thawed plasma for thawed platelets in saline in the 
assay. 
ÇytQSoUç 
Cytosolic calcium was determined using the fluorescent calcium 
indicator quin-2 in a modification of the method described by Hallam 
et al. (1984). One ml of 40 pM quin-2/acetoxymethyl (AM) (Molecular 
Probes, Inc., Eugene, OR) in HBS was added to each tube containing 1 
ml suspended platelets and the tubes were incubated for 30 min in a 
Z7X water bath to allow the platelets to incorporate the quin-2/AM, 
The tubes were then centrifuged at 400 X g for 20 min to sediment 
the platelets. The quin-2/AM in HBS was decanted and the tubes 
were blotted on adsorbant paper to remove all the quin-2/AM not 
within cells. Two ml HBS was then added, and the platelets were 
resuspended by gentle vortexing. The tubes were then incubated in 
the Z7X water bath for at least 1 h to allow complete hydrolysis of 
the AM groups. 
Fluorescence (F) of 1 ml of the quin-2 loaded platelets was 
determined in a Z7X thermostatically regulated quartz cuvette in a 
Model J4-8965 Amino Bowman Spectrofluorometer with excitation 
wavelength 340 nm (slit width 1 mm) and emission wavelength 
492 nm (slit width 1 mm). The maximal fluorescence (Fmax) of the 
quin-2 trapped within the cells was determined by adding 100 pi of 11% 
Triton X-100 in water containing 0.956 g% CaCl2 to lyse the cells and 
make the final calcium concentration 1 mM. The minimum 
fluorescence (Fmin) of the quin-2 then was determined by adding 100 
nl of 2 mM ethylene glycol-bis(^-aminoethylether)I\I,N,N',N'-tetraacetic 
acid (Sigma Chemical Co., St. Louis, MO) which was dissolved in 3.8 g% 
KOH. The addition of this alkaline calcium chelator resulted in a pH of 
approximately 8.5 and served to release all calcium from the quln-2. 
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Autofluorescence of pooled platelets In HBS was determined for F, 
Fmax, and Fmin using the procedures for cells loaded with quin-2 and 
these values were subtracted from all values for F, Fmax, and Fmin 
in calculations. Cytosolic calcium ([Ca++]i) was determined using the 
equation of Tsein et al. (1982): [Ca++]i = Kd (F-Fmin)/((Fmax-F); Kd = 
115 nM. 
PhQgpHQUpage Ap 
Platelet phospholipase A2 (PLA) activity was assayed by using a 
modification of the procedure of Ballou and Cheung (1983) as 
previously described (Krumhardt, 1989b). Briefly, a 360 nl aliquot of 
the washed platelets in pH 7.5 TRIS/NaCl Buffer was incubated at 37*C 
with 40 \xl of substrate which contained approximately 0.03 ^Ci of 1-
Palmitoyl-2-[l-l'^C] arachidonyl-572-glycerol-3-phosphatidyl choline, 
specific activity 52.0 mCi/mmol, (New England Nuclear, Boston, MA) in 
substrate buffer containing 50 mM taurocholic acid, 20 mM calcium 
chloride, and 0.05 g% fatty acid free bovine serum albumin in 
TRIS/NaCl. At substrate addition and after 40 minutes Incubation, 
[1-1'^C] arachidonic acid released in each aliquot was separated from 
labeled substrate using thin-layer chromatography with ethyl 
acetate: acetic acid (99:1, v/v) as the solvent system. Radioactivity 
associated with released [l-l'^C] arachidonic acid and substrate [l-l'^C] 
phosphatidyl choline was determined by liquid scintillation counting. 
To determine the percentage of labeled phosphatidyl choline 
substrate which was associated with platelets after 40 min 
incubation, 50 ^1 aliquots of platelet PLA assay samples were added to 
1 ml TRIS/NaCl and centrifuged at 3000 X jfor 10 min to sediment 
the platelets. Radioactivity associated with the pelleted platelets and 
the supernatant were determined by liquid scintillation counting as 
described above. For all samples for which uptake of tracer was 
determined in this manner, 53 ± 2% of the radioactivity was 
associated with the platelets after 40 min. 
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Thromboxane B2 
At the same time points as for the PLA assay, 50 nl aliquots of 
the PLA assay reaction mixture were added to 10 pil of 42mM Aspirin 
in TRIS/NaCl to stop TX synthesis. The samples were frozen on dry 
ice and stored at -20'C. Double antibody radioimmunoassay of TX 
using ^H-TX (New England Nuclear, Boston, MA) to competitively bind 
antibody was performed as described by McCosh et al, (1976) and 
Steinberg et al. (1982), with dual channel counting used to correct for 
the activity in the samples. The TX antiserum had a cross-
reactivity with 6-Keto prostaglandin Fia of 20%. No correction was 
made for this cross reactivity. The concentration of I'^C-TX in these 
samples was too small to determine the amount of I'^C-TX 
synthesized from the PLA assay substrate, so only endogenously 
derived TX was determined. 
ProtQm 
All of the remaining platelet suspension was frozen on dry ice 
and stored at -20X for later protein analysis which was performed 
by using the procedure of Lowry et al. (1951). Fatty acid-free bovine 
serum albumin fraction V (Sigma Chemical Co,, St. Louis, MO) was 
used as the protein standard. The protein concentration of platelet 
suspensions was used to standardize for small differences in platelet 
numbers in the PLA and TX assays. 
Statistical methods 
All analyses were done in duplicate for each sample. Statistical 
analyses were done using the General Linear Model, Least Squares 
Means, and Pearson Correlation Coefficients procedures of Statistical 
Analysis System, version 5.16, Cary, N.C. Analyses were performed 
grouping the subjects by diet habit group. Because there was no 
difference in the en% linoleate reported by diet habit groups, the 
platelet and plasma fatty acid, cytosolic calcium, phospholipase A2 
activity, and thromboxane synthesis data were regrouped for 
statistical analyses by percentage linoleate reported to reflect low, 
medium, and high linoleate Intakes. Reported linoleate intake from 
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2.5 to 5,0 en% was termed low (n = 6); reported llnoleate Intake from 
5,0 to 8,0 en% was termed medium (n = 12); and reported linoleate 
intake above 8.0 en% was termed high (n = 5). 
Results 
Subjects 
The Body Mass Index (BMI) of subjects was not significantly 
different due to dietary groups. The mean for all subjects was 23.6 
with a standard deviation of 2.7 (range: 19,7-31,1), This value is 
slightly, but not significantly, lower than the BMI of 24,7 kg/m^, 
which corresponds to a relative body weight (relative body weight = 
weightAstandard weight for height) X 100) of 100$ (Grande, 1984), 
Piets 
The results of the dietary nutrient composition analysis of the 
24-hour food intake records for major nutrients and dietary lipid 
components are shown in Table 1. There was no difference due to 
dietary grouping in percentage of protein, polyunsaturated fat, or 
linoleic acid. The percentage carbohydrate reported by vegans was 
significantly higher than that reported by OLV which was 
significantly higher than that reported by OMNI, This difference 
corresponded to a significantly lower percentage fat and saturated fat 
consumption by vegans. Because vegans reported less total fat but 
not significantly less polyunsaturated fat or linoleic acid, their dietary 
P/S ratio was considerably, and significantly, higher than that of the 
other two groups (1.75 versus 0,68 and 0.48, respectively). OLV 
reported a significantly higher percentage of monounsaturated fat 
than vegans, and vegans reported a significantly higher percentage 
monounsaturated fat than OMNI, Because cholesterol is only present 
in animal-derived foods, vegans reported no cholesterol and this 
resulted in a significantly lower consumption of cholesterol by this 
group. The difference in cholesterol consumption was not significantly 
different between OLV and OMNI, 
Table 2 shows the results of the analysis of these records for 
nutrients which have established Recommended Dietary Allowances 
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Table 1. Average dietary Intakes of diet habit groups for 
major nutrients and dietary lipid components 
Diet component 
Diet Habit Group 
Vegan OLV OMNI 
n = 3 n = 9 n = ll 
Protein (en%) 
Carbohydrate (en$) 
Fat (en%) 
Saturated Fat (en%) 
Monounsaturated Fat (en%) 
Llnoleate (en%) 
P/S Ratio 
Cholesterol (mg/dav) 
Mean ± SEM 
15.9±2.4 13,1±1.4 16.1+1,2 
53.0+3,3* 47,8+3,0* 
34.4+3,1* 34.5+2,8* 
13.6±2,0 17,4±1.8** 
12.6+1.5 9.3+1.3 
6.6+0.8 6.2+0.7 
68.5+5.7* 
21.0±5.4* 
5.4±3.5** 
6.9+2.5 
7.0±1.4 
1.75±0.28** 
O.OiO.O* 
0.68±0.16** 0.48±0.15** 
313±91* 374+82* 
*Slgnlflcantly different due to diet habit group by least squares 
means analysis, P< 0.05. 
**Significantly different due to diet habit group by least squares 
means analysis, /'< 0.01. 
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Table 2. Average dietary Intakes of diet habit groups for 
nutrients having Recommended Dietary Allowances 
(1980) 
Diet Habit Group 1980 
Diet component Vegan OLV OMNI RDA^ 
n = 3 n = 9 n = 11 
Mean ± SEM 
Protein (g) 100+38 96+22 124+20 56 
Vitamin A (lU) 31431±11195 2507216464 732815847 5000 
Vitamin C (mg) 522±1807 2584±1043 1981943 60 
Thiamin (mg) 5.1±6.7 10.8±3.8 2,213.5 1.4 
Riboflavin (mg) 2.8+6.6 10.4±3.8 2,813.5 1,6 
Niacin (mg) 35±44 73±25 34123 16 
Calcium (mg) 1283+412 14801238 11921215 800 
Phosphorous (mg) 2102±636 20271367 19821332 800 
Iron (mg) 46+10 3816 2315 10' 
^Recommended Dietary Allowance (RDA) (Committee on Dietary 
Allowance, Food and Nutrition Board, Division of Life Sciences, National 
Research Council, 1980). 
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(RDA) (Committee on Dietary Allowances, Food and Nutrition Board, 
Division of Life Sciences, National Research Council, 1980). The average 
daily energy intake for vegans was 2612 ± 512 kcal. For OLV, the 
average daily energy intake was 2954 ± 296 kcal. For OMNI, the 
average daily energy intake was 3012 ± 296 kcal. There was no 
statistically significant difference in energy intake due to diet habit 
group. All subject energy intakes were within or above the range of 
the Estimated Safe and Adequate Intake for energy (2300-3100 kcal) 
(Committee on Dietary Allowances, Food and Nutrition Board, Division 
of Life Sciences, National Research Council, 1980). 
Table 3 shows the average dietary intakes of linoleate intake 
groups for major nutrients and dietary lipid components. Grouping 
by dietary reported linoleate intake resulted in mean reported 
linoleate intakes of 4.0, 6.1, and 10.3 en% linoleate for the low, 
medium, and high linoleate intake groups, respectively. The group 
with low reported linoleate intakes had a significantly higher intake 
of protein as compared with the other linoleate intake groups. The 
group with .high reported linoleate intakes reported a significantly 
higher proportion of fat and monounsaturated fat in their diet as 
compared with the other linoleate intake groups. Intake of 
carbohydrates, saturated fat, cholesterol, and the dietary P/S ratio 
were not significantly different when the data were grouped in this 
manner, 
Platelet fattv acids 
Table 4 shows the results of the platelet fatty acid analyses 
when data were grouped by diet habit. There were no differences 
due to diet habit group in the percentage of myristic, stearic, oleic, 
linoleic, or arachidonic acid in the platelets. However, there was a 
trend (P< 0.07) for vegans to have a lower percentage of arachidonic 
acid in their platelets. The percentage of palmitic acid in the platelets 
of vegans was significantly higher than that of OMNI. The percentage 
of palmitoleic acid in the platelets of vegans was significantly lower 
than that of OMNI. The percentage of linolenic acid in platelets of 
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Table 3. Average dietary Intakes of linoleate Intake groups 
for major nutrients and dietary lipid components 
Linoleate Intake Group 
Low Medium High 
2.5-5.0 5.0-8.0 8.0-11.1 
n = 6 n = 12 n = 5 
Mean ± SEM 
Protein (en%) 18.2+1.5* 14.4±1.1 12.111.7 
Carbohydrate (en%) 52.6±4.9 54.1±3.4 48.615.3 
Fat (en%) 27.7±3.9 32.2±2.7 39.915.3* 
Saturated Fat (en%) 10.3±2.2 11.1+1.6 10.712.4 
Monounsaturated Fat (en%) 7,1+1.6 8.2+1.1 13.711,8* 
Linoleate (en%) 4.0±0.3** 6.110.2** 10.310.3** 
P/S Ratio 0.81±0.25 0.55±0.17 1.0410.28 
Cholesterol (mg/dav) 396+117 314183 1561129 
^Significantly increased due to linoleate intake group by least 
squares means analysis, P< 0.05, 
^^Significantly different due to linoleate intake group by least 
squares means analysis, P< 0,0001, 
Diet component 
Linoleate intake (en%) 
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Table 4. Platelet total fatty acid composition for diet habit 
groups 
Diet Habit Group 
Fatty acid Vegan OLV OMNI 
n = 3 n = 9 n = 11 
Percent of Total i : SEM 
Myrlstate 1.4+0.5 1.3±0.3 0.5±0.3 
Palmitate 27.9+1.9* 25.3±1.0 23.5±1.0* 
Palmitoleate 0.0±0.7* 0.810.4 1.9±0.4* 
Stearate 23.7±2.2 24.9+1.3 25,8±1.1 
Oleate 26,6+2,2 22.9+1,3 23.3±1.2 
Linoleate 8.5+1.5 8.6±0,9 7.6±0.8 
Linolenate 0.0±0.4* 0.6±0.3 1.1±0.2* 
Eicosatrienoate 0,1±0.5* 0.5±0.3 1,2±0.2* 
Arachldonate 9.8±2.4 15,2±1,4 15.111.3 
^Significantly different due to diet habit group by least squares 
means analysis, P< 0.05. 
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OMNI was significantly higher than that in platelets of vegans, The 
same trend was apparent in the percentage of eicosatrienoic acid, 
with OMNI having a significantly higher percentage of eicosatrienoic 
acid than vegans. 
Table 5 lists the results for platelet fatty acid analyses when 
the data were grouped by reported linoleate intake. The low linoleate 
intake group had a significantly lower percentage of linoleate in their 
platelets. The percentage of arachidonic acid was lower and the 
percentage of stearic acid and palmitic acid was higher, but not 
significantly so, in the platelets of the low linoleate intake group. 
These differences, when combined, made up for the lower linoleate 
percentage of fatty acids in this group. 
There was no correlation of percentage of dietary linoleic acid 
with the percentage of linoleic acid or any other fatty acid in 
platelets when the data were analyzed for all subjects. However, 
when the percentage of dietary linoleate was less than 8.0, the 
percentage of platelet linoleic acid was correlated with the percentage 
of dietary linoleate (r = 0.50, P< 0.04). There was no correlation 
between the percentage of dietary linoleate and platelet percentage of 
linoleate when dietary linoleate was greater than 8.0 en%. The 
relationship between dietary linoleate percentage and platelet 
linoleate is shown in Figure 2. The line in this figure represents the 
line derived by linear regression of the points representing intakes of 
less than 8.0 en% linoleate. 
Plasma fattv acids 
Table 6 shows the percentage composition of total plasma fatty 
acids when data were grouped by diet habit. The only plasma fatty 
acid which was significantly effected by diet habit was arachidonic 
acid, which was significantly lower in OLV and highest in vegans, 
Table 7 shows the result of fatty acid analyses when the data were 
grouped by reported linoleate intake. The low linoleate intake group 
had a significantly lower percentage of linoleate in their plasma total 
lipids as compared with the high linoleate intake group. There was 
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Table 5. Platelet total fatty acid composition for low, 
medium and high linoleate intake groups 
Linoleate Intake Group 
Fatty acid Low Medium High 
Linoleate intake (enZ) 2.5-5.0 5.0-8.0 8.0-11.1 
n = 6 n = 12 n = 5 
Percent of Total: Mean ± SEM 
Myristate 0.9+0.4 0.9+0,3 1.1+0.4 
Palmitate 25.6±1.5 24.3±1.0 24.9±1.6 
Palmitoleate 1.7±0.6 1.1±0,4 0.9±0.6 
Stearate 26.9±1,5 23.2+1.1 22,7+1.8 
Oleate 25.0+1,6 23.2+1.1 22,7±1,8 
Linoleate 5.6±0.9* 9.1±0,6 8.6±1.0 
Linolenate 1.0±0.3 0.6±0.2 1.0+0.4 
Eicosatrienoate 1.0±0.4 0,7±0.3 0,7±0.4 
Arachidonate 12.3+1.8 15.7±1.3 21,0+5,0 
^Significantly different due to linoleate intake group by least 
squares means analysis, P< 0.05. 
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Figure 2. Dietary linoleic acid effects on platelet linoleate. 
Line = regression of platelet linoleate versus 
dietary linoleate when dietary linoleate was from 
2.5 to 8.0 en% (r = 0.50, /»<0.04) 
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Table 6. Plasma total fatty acid composition for diet habit 
groups 
Diet Habit Group 
Fatty acid Vegan OLV OMNI 
n = 3 n = 9 n = 11 
Percent of Total: Mean ± SEM 
Myristate 0.8±0.1 1.3±0.2 1.1+0.1 
Palmitate 22.0+1.1 22.1+0.6 22.7+0.6 
Palmitoleate 2,4±0,5 2.6±0.3 2.7±0.2 
Stearate 6.6±0.6 6.9+0.3 7,2+0.3 
Oleate 21.2±2.0 23.1+1.2 22.5+1.1 
Linoleate 37.1+2.8 36.9+1.6 35,4+1.5 
Linolenate 0.2±0.2 0,2±0.1 0.4±0.1 
Eicosatrienoate 0.8+0.3 1.1+0.2 1.2+0,1 
Arachldonate 8.7±0.7* 5.5±0.4* 6.4±0.4* 
^Significantly different due to diet habit group by least squares 
means analysis, P< 0,01. 
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Table 7. Plasma total fatty acid composition for low, 
medium and high linoleate intake groups 
Linoleate Intake Group 
Fatty acid Low Medium High 
Linoleate intake (enZ) 2.5-5.0 5.0-8.0 8.0-11.1 
n = 6 n = 12 n = 5 
Percent of Total: Mean ± SEM 
Myristate 1.1±0.2 1.3+0.1 0.9±0,2 
Paimitate 23.7±0.7* 22.2±0.5 21.3±0.8« 
Palmitoleate 2.8±0.3 2.6±0,2 2.4±0.4 
Stearate 6,7±0.4 7.0+0.3 7,4±0.4 
Oleate 25.3+1.3* 21.9+0,9 20,8±1.4 
Linoleate 33,0±1.8** 36.2±1.2 39.9±1.9«« 
Linolenate 0.2±0.1 0,4+0,1 0.2±0,1 
Eicosatrienoate 1.0+0.2 1.2±0.1 1.0+0.2 
Arachidonate 5,9+0,6 6,8+0,5 5,9+0.7 
«Significantly different due to linoleate intake group by least 
squares means analysis, P< 0.05. 
««Significantly different due to linoleate intake group by least 
squares naeans analysis, P< 0.01. 
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no significant difference in the percentage of linoleate in the plasma 
of the medium linoleate intake group as compared with either other 
group. The difference in linoleate percentage in plasma was 
concurrent with a significant increase and decrease in plasma 
palmitate for the low and high linoleate intake groups, respectively, 
The only fatty acid of plasma which correlated with the same 
fatty acid in platelets was eicosatrienoic acid (r = 0.56, P< 0.005). 
There was a positive correlation of platelet palmitoleic acid with the 
percentage of saturated fat in the diet (r = 0.47, P< 0.02). 
There were several correlations of plasma fatty acids with 
dietary fat analyses. Plasma myristic acid correlated negatively with 
dietary P/S ratio (r = -0.53, P< 0.01). The percentage of 
monounsaturated fat in the diet correlated with plasma palmitic acid 
(r = -0.52, P< 0.01). Both polyunsaturated fat, and linoleic acid, a 
component of the polyunsaturated fat, in the diet were correlated 
with plasma palmitic acid in the same manner (r = -0.51, P< 0.01). 
Plasma linoleic acid was correlated with the monounsaturated dietary 
f a t  ( r  =  0 . 5 7 ,  P <  0 . 0 0 5 ) ,  t h e  p o l y u n s a t u r a t e d  d i e t a r y  f a t  ( r  =  0 . 6 4 ,  P <  
0.001), and the percentage of linoleic acid (r = 0.62, P< 0.002), Plasma 
linolenic acid was negatively correlated with percentage of 
polyunsaturated fat (r = -0.50, P< 0.02). 
Cvtosollc calcium 
Table 8 shows the values for the means of linoleate intake 
groups for resting cytosolic calcium. There were no significant 
differences between groups when the data were grouped by either 
linoleate intake group or diet habit group (data not shown). 
Moreover, the range for all subjects was only from 84 to 124 nM 
with an overall standard deviation of only 11 nM. 
PhosDholipase A2 activity and thromboxane B2 synthesis 
Table 9 shows the results of the platelet PLA activity and TX 
synthesis analyses when the data were grouped by diet habit. There 
were no significant differences due to diet habit group in any of the 
measures. Table 10 shows the results of the platelet PLA activity and 
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Table 8. Platelet cytosollc free ionized calcium ([Ca**]0 for 
low, medium and high linoleate intake groups 
Linoleate Intake Group n [Ca**3i (nM)^ 
Mean ± SEM 
Low 6 107±5 
Medium 12 105±3 
High 5 98±5 
^No significant difference by least squares means due to 
linoleate intake group, 
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Table 9. Platelet phospholipase A2 activity and thromboxane 
B2 synthesis for diet habit groups 
Diet Habit Group 
Vegan OLV OMNI 
n = 3 n = 9 n = 11 
Mean ± SEM 
PLA activity^ 82±34 80±20 59±18 
TX synthesis^ 19.1+7.2 8.5±4.2 15.2±3.8 
âpmol arachidonate released/mg platelet protein in 40 minutes. 
No significant difference by least squares means due to diet habit 
group. 
l^pmol TX syntheslzed/mg platelet protein in 40 minutes. No 
significant difference by least squares means due to diet habit group. 
Table 10. Platelet phospholipase A2 activity and 
thromboxane B2 synthesis for low, medium and 
high linoleate intake groups (mean ± SEM) 
Linoleate Intake Group 
Low Medium High 
Linoleate intake (enX) 2.5-5.0 5.0-8.0 8.0-11.1 
n = 6 n = 12 n = 5 
PLA activity^ 63.5±24.7 67.3±17.5 84,4+27,1 
TXb 19.1±4.5 6.8±5.2* 21.0±5.0 
^pmol arachidonate released/mg platelet protein in 40 minutes. 
No significant difference by least squares means due to linoleate 
intake group, 
^pmol TX synthesized/mg platelet protein in 40 minutes. 
Significant difference due to linoleate intake group by least squares 
means, P< 0.05, 
* Significantly different due to linoleate intake group by least 
squares means, P< 0.04. 
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TX synthesis analyses when the data were grouped by diet reported 
llnoleate intake, When the data were grouped in this way the 
mediunn linoleate intake group had significantly lower TX synthesis as 
compared with the other two groups (P< 0,04). A quadratic 
regression line for correlation of dietary linoleate with TX synthesis 
suggests that a non-linear relationship exists between the two (r = 
0.41) (Figure 3). However, the same group did not have significantly 
decreased net PL A activity as compared with the other two groups. 
There was no difference due to linoleate intake group in net PLA 
activity. However, TX synthesis in platelets was positively correlated 
with net PLA activity (r = 0.47, P< 0.02). The percent of platelet 
eicosatrienioc acid was correlated with the amount of TX synthesized 
after stimulation with collagen (r = 0.45, P< 0.03). However, there 
were no correlations with the percentages of any other platelet fatty 
acids and net PLA activity or TX synthesis. 
Discussion 
Subjects and diQtg 
It was expected that vegans would report a higher proportion of 
their Kcal as linoleic acid than would consumers of animal products. 
Contrary to expectations, there were no significant differences 
between groups in reported dietary percentage of linoleate. The 
differences between the groups in overall dietary fat did conform to 
expectations because vegans reported less total and saturated fat 
than the other two groups. 
In spite of this finding, there were large difference in reported 
linoleate intake in the subjects studied. When the data were grouped 
by low (2.5 to 5.0 en%), medium (5.0 to 8,0 en%), and high (8.0 to 11,1 
en%) reported linoleate intake, the significant differences between 
groups in P/S ratio and dietary cholesterol were diminished, leaving 
only significant differences in percentages of protein and fat. Because 
all subjects reported sufficient protein to meet the RDA for this 
nutrient, it may be assumed that the excess Kcal provided by protein 
in the low linoleate intake group was utilized for energy needs. 
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3 4 5 6 7 8 9 10 11 12 
Dietary Linoleate (en%) 
Figure 3. Effect of dietary linoleate on thromboxane 
synthesis 
With Y = pmol thromboxane synthesized per mg 
platelet protein, and X = en% dietary linoleate, the 
equation for the line is: Y = 43.8 - 10.5X + 0.8X2 (r = 0,41). 
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Additionally, the high intake of Kcal as fat and monounsaturated fat 
by the high linoleate intake group might have been primarily used to 
provide energy because caloric intake was not significantly affected by 
linoleate intake grouping (data not shown). This grouping, then, 
provided a reasonable illustration of the effects of dietary linoleate 
upon the measures of platelet and plasma fatty acids, platelet 
cytosolic calcium, and platelet TX synthesis and net PL A activity. 
Platelet fattv acids 
The linear relationship of platelet linoleate with dietary linoleate 
up to 8.0 en% is analogous to the same relationship found by feeding 
rats diets providing 3.0 to 9.0 en$ linoleate and 30 en% total fat 
(Krumhardt, 1989b). The correlation is not as strong as the 
relationship found in the rats, but considering the complexity of the 
diets reported by the subjects in this study, it seems to confirm that 
dietary linoleate is an important factor in the control of the linoleate 
content of platelets. However, when linoleate was greater than 8,0 
and up to 11,1 en% there was not a linear relationship between intake 
and platelet fatty acid composition. Indeed, it seems that the rise in 
the percentage of linoleate in platelet fatty acids leveled off when 
reported linoleate intake exceeded 8,0 en%. At the higher levels of 
linoleate consumption, it seems that other factors must strongly 
influence platelet linoleate composition, There were not enough data 
points in this range of linoleate consumption to determine what those 
factors might be. However, perhaps an upper limit on platelet 
linoleate percentage in humans is reflected by this data. Other 
researchers have found a similar relationship of dietary linoleate to 
platelet linoleate (Davenas et al., 1984, Renaud et al., 1970 and 1986). 
The data reported herein indicate that platelet linoleate may be 
useful to indicate linoleate intake. Indeed, because platelet linoleate 
percentage may be determined accurately in the laboratory and 
dietary linoleate intake may only be estimated by dietary records, 
using platelet linoleate to deduce linoleate intake may more 
accurately indicate linoleate intake than three-day diet records. 
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More research on a larger population is required, however, to 
determine if the results reported herein are applicable to all persons, 
regardless of sex, age, race, or other factors. However, the results 
reported herein indicate that consumption of diets that differ in 
protein sources does not affect platelet linoleate percentages. 
Plasma fattv acids 
There were several correlations of plasma fatty acids with 
dietary fat components. It is interesting that only fatty acids which 
comprise less than 2.0% of total fatty acids are correlated with 
measures of dietary fat. The lack of correlation of plasma fatty acids 
present in higher proportions with measures of dietary fat is 
consistent with the results of Reeves et al. (1984). However, there 
were significant differences in plasma palmitate and linoleate when 
the data were grouped by linoleate intake group. This indicates that 
lower linoleate consumption results in a lower linoleate percentage in 
plasma fatty acids, despite the lack of correlation between the two for 
the same measures in individuals. This decrease in the linoleate 
percentage in plasma in groups consuming a low linoleate intake is 
made up for by a higher percent of palmitate in the plasma in the 
same group. This suggests that there are inherent inaccuracies in the 
determination of dietary linoleate using the three-day food records, 
and, that these inaccuracies may be minimized by grouping the data 
for individuals into low, medium, and high linoleate intake groups as 
we have done. 
Cvtosolic calcium 
The lack of difference in resting cytosolic calcium due to diet 
demonstrates that differences in the fat content and composition of 
diet did not affect this measure in these men. This corresponds well 
to the same lack of effect shown in male rats fed diets constant in 
content of fat, and all other nutrients, but different in the fatty acid 
composition (Krumhardt, 1989a). It appears that cytosolic calcium 
regulation is not the entity which provides a cellular mechanism for 
the physiological effects of differences in dietary fat in either humans 
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or rats. It is probable that less central controls of platelet activity 
are affected by dietary fat composition and content. 
PhQsphotipaigQ A2 activity 
These results suggest that net PLA activity is a regulator of TX 
synthesis in human platelets, as it is in rat platelets (Krumhardt, 
1989b), because the correlation between the two is statistically 
significant. However, it seems that regulation of PLA activity in 
humans is not by way of dietary linoleate, because there was no 
significant difference in net PLA activity when the data were grouped 
by low, medium, and high linoleate Intakes, Also, there was no 
correlation between reported linoleate intake and net PLA activity or 
difference due to dietary linoleate intake group. This may indicate 
the endogenous inhibitor of human platelet PLA described by Ballou 
and Cheung (1985) is not modified by dietary fat composition, even 
though these researchers have found that the inhibitor appears to be 
a lipid, and probably a polyunsaturated fatty acid, 
There is significantly less platelet net PLA activity in humans as 
compared with Sprague Dawley rats of about the same physiological 
age and the same sex. The overall mean for net PLA activity was 
381 pmol arachidonic acid released per mg platelet protein in 40 min 
in rats fed experimental diets; and the overall mean for the same 
measure in humans was 70 pmol arachidonic acid released per mg 
platelet protein in 40 min. Moreover, in rats the uptake of 
phosphatidyl choline tracer was 50%, as compared with 53% uptake 
observed with human platelets. Therefore, differences in uptake of 
tracer in this assay do not account for the differences in activity 
observed. This, along with the lack of influence of dietary reported 
linoleate intake upon PLA activity, indicates that, in humans, PLA 
activity is more tightly regulated than in rats, and, that the 
regulation is not influenced by dietary fat as in rats. The endogenous 
inhibitor of PLA described by Ballou and Cheung (1985) may play a 
role in this regulation. More work is required to determine if the 
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endogenous Inhibitor of PLA in human platelets is unique to the 
human species. 
Another possible explanation of the lack of dietary linoleate 
effect on PLA activity as measured in this study is that an 
arachidonate-specific acyl-coenzyme A synthetase found in human 
platelets may play a role in actively re-incorporating freed labeled 
arachidonic acid into cell phospholipids (Neufeld et al,, 1983). This 
assay would not distinguish freed and re-incorporated arachidonic acid 
from labeled phosphatidyl choline substrate. If the re-incorporation of 
arachidonic acid freed by PLA is greater in humans than in rats, 
then the differences in net PLA activity found in these two studies 
might be the result. However, a specific study to determine this 
effect, if it exists, was not done. 
Thromboxane B2 synthesis 
Synthesis of TX was significantly lower in platelets of persons 
consuming a medium linoleate diet and the TX synthesis of both low 
and high linoleate intake groups was significantly higher. In our 
laboratory, we have obtained similar results for several tissues when 
eicosanoid synthesis was determined after dietary fat manipulation 
(Dupont and Dowd, 1989). Increased platelet eicosatrienoate has been 
associated with decreased TX synthesis (Sprecher and Careaga, 1986). 
The lack of difference in the percent platelet eicosatrienoate between 
linoleate intake groups may indicate that platelet eicosatrienoate is 
not causing the effect we have observed, 
Conclusions 
Platelet linoleate is increased by increasing amounts of linoleate 
in the diet, but this increase levels off at 8,0 en$ linoleate, Cytosolic 
calcium in resting platelets is not affected by platelet or diet linoleate. 
Inhibition of net PLA activity by platelet or dietary linoleate does not 
appear to occur in humans as it does in rats (Krumhardt, 1989b), 
However, intermediate linoleate intakes (from 5,0 to 8.0 en%) result in 
lower platelet TX synthesis as compared with lower and higher 
linoleate intakes. This indicates that Intermediate linoleate intakes 
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would be beneficial to the health of most individuals because high 
elcosanoid synthesis is generally associated with pathological conditions 
(Dupont, 1987), and higher (over 3 fold) transcardiac TX synthesis is 
specifically related to recent episodes of angina pectoris as compared 
with other coronary problems (Hirsh et al., 1981), 
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GENERAL DISCUSSION 
Platelet Fatty Acids 
The results of the experiments reported in this dissertation 
indicate that platelet percentage linoleate increases linearly by feeding 
rats diets with increasing percentages of linoleate to provide from 3.0 
to 9.0 percent of Kcal (en%), The actual percentages of linoleate and 
other fatty acids in platelets were not consistent between the two rat 
feeding experiments. Two different strains of rats were used for the 
two experiments and this may account for the differences in the 
fatty acid profiles of platelets determined for the two experiments. It 
would appear, then, that non-obese Zucker rats generally have higher 
percents of oleic and linoleic acid and lower percents of palmitic and 
arachidonic acids as compared with Sprague Dawley rats. Despite the 
differences in general fatty acid profiles between the two rat strains, 
the trend for a linear relationship between dietary and platelet 
linoleate was consistent. 
In the human study, a wider range of linoleate consumption 
was examined than with either rat study. This wider range gave 
new Insight into the effect of dietary linoleate upon platelet linoleate. 
The results of this study showed that platelet linoleate is correlated 
with dietary linoleate when dietary linoleate provides from 2.5 to 8.0 
en%. Linoleate consumption higher than 8.0 en% does not correlate 
with platelet linoleate, indicating that the percent linoleate in human 
platelets levels off at less than 10% due to factors other than dietary 
linoleate; however, this effect may be due to inaccuracies inherent in 
the method used to estimate linoleate intake. Visual inspection of a 
graph of en% dietary linoleate plotted versus platelet percent linoleate 
for the data of the experiment reported in paper II indicates that 
some degree of leveling off in the rise in platelet percent linoleate is 
occurring in these rats when the 9,0 en% linoleate diet is fed. A 
study exploring the effects of feeding 6.0, 7.5, 9.0, 10.5, and 12.0 en% 
linoleate diets composed of equal total fat with equal cholesterol 
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would determine if leveling off in the percent llnoleate incorporated 
into platelets occurs in rats as it appears to occur in humans. 
Human platelet fatty acid profiles are different from those of 
either strain of rat used for experimental studies. Rats had higher 
percentages of palmitic acid than humans. Humans had higher 
percentages of stearic acid and, in most cases, oleic acid than rats. No 
other obvious general differences in platelet fatty acid profiles were 
found when the results of the three studies reported in this 
dissertation were compared. 
For both species, a general conclusion about dietary linoleate 
effects on platelet linoleate may be made. The results presented in 
this dissertation demonstrate that the fatty acid profile of platelets is 
affected by dietary linoleate content, The effect is a positive linear 
correlation between the two with diets providing 2,5 to 8.0 en% 
linoleate, and with dietary linoleate higher than 8.0 en%, the percent 
linoleic acid in platelets reaches a plateau. 
Platelet Cytosolic Calcium 
The results presented in papers I and III both indicate that 
resting cytosolic free ionized calcium is not affected by dietary 
linoleate. This would suggest that the effects of dietary linoleate on 
platelet fatty acid profiles produce no net changes in the results of 
the operation of the several enzymes and ion transporters which 
control cytosolic calcium. 
Platelet Phospholipase A2 Activity 
In rats, feeding of diets which increase the percentage of linoleic 
acid In platelets effects inhibition of net phospholipase A2 (PLA) 
activity when diets fed provide from 4.5 to 9.0 en$ linoleate. This 
does not appear to be the case in humans, however, because there 
was no effect of dietary linoleate found in the human study reported 
in this dissertation. Additionally, human net PLA activity was much 
lower than that in rats. As discussed in paper III, this could just be 
an artifact of the way PLA was assayed. Further study is needed to 
determine if this is the case. In order to determine the relationship 
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of dietary linoleate less than 4.5 en% to PL A activity in rats, an 
experiment comparing 1, 2, 3, 4, and 5 en% linoleate should be 
conducted. . 
Platelet Thromboxane Synthesis 
The results presented in paper I indicate that isolated rat 
platelet thrombin-stimulated thromboxane (TX) synthesis is not 
affected by dietary linoleate. The blood samples for this study were 
collected from rats which had access to food at all times. Because 
rats generally eat in the middle of the night, the samples could be 
said to have been collected in the fasted state (Samples were collected 
between 8:30 and 10:00 AM.). Sullivan and Mathias (1982) found that 
differences in whole blood TX synthesis due to dietary linoleate found 
in fed rats were not present in fasted rats. Moreover, as stated in 
paper I, the incubation time of the platelets before collection of 
samples for TX analysis was relatively long which might have 
contributed to this effect. However, the data presented in papers II 
and III, which were determined using samples from rats fed a meal 
and from humans who had eaten their usual breakfast, indicate a 
relationship between the two. As discussed in the general 
introduction, both increased and decreased TX synthesis have been 
reported in the literature in association with Increases in dietary 
polyunsaturated fat (Mathias and Dupont, 1985), Therefore, it is not 
surprising that different results were obtained for the three studies, 
especially because the techiques used for stimulating the platelets 
were different and two species (and two strains of rats) were 
examined. 
In humans, the lowest TX synthesis was associated with 
medium linoleate intakes (from 5.0 to 8.0 en% linoleate). Because 
increased platelet TX synthesis is thought to be associated with 
cardiovascular disease, it would be prudent to recommend intakes of 
linoleic acid in this range. Intakes in this range would not be 
considered extreme and would agree with the American Heart 
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Association (1978) recommendations that polyunsaturated fat account 
for up to 10% of total calories in the diet. 
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Effect of pH on Phospholipase A2 Activity 
To determine the effect of pH on phospholipase Ag (PLA) 
activity in whole platelets, assays of PLA were performed using 
TRIS/NaCl Buffers of different pH's in addition to the pH of 7,5 which 
was used for the assays reported in papers II and III of this 
dissertation. Assay conditions and methodology were the same as 
described in paper II, with the substitution of TRIS/NaCl buffers of 
different pH's for the pH 7.5 TRIS/NaCl buffer as required. 
For the PLA assay in rat platelets, pH's of 7.0, 7,5, 8.0, 8,5, and 
9,0 were used. Platelets were isolated in TRIS/NaCl buffers adjusted 
to these pH's. When the pH 8.5 and 9.0 buffers were used, platelets 
aggregated during isolation. Therefore, the PLA assay was not 
performed for these pH's. The time course of this assay Is shown in 
Figure 1. The highest activity was observed with a pH of 8.0, and the 
lowest activity was associated with a pH of 7,0. The pH of 7.5 was 
chosen for the measurement of PLA in platelets of rats fed 
experimental diets because it better reflected in vivo conditions than 
pH 8.0, and the activity was higher than that observed with pH 7,0, 
For the PLA assay in human platelets, the effect of suspending 
the platelets in pH 7.0, 7,5, and 8.0 TRIS/NaCl buffers was determined. 
The time course for this assay is shown in Figure 2. The effect of pH 
on human platelet PLA activity was found to follow the same trends 
as for rat platelet PLA activity. The pH 7,5 TRIS/NaCl buffer was used 
to best represent in vivo conditions and, also, to allow comparison of 
data between the two studies. 
Effect of Platelet Preparation Method on Phospholipase A2 
Activity and Thromboxane Synthesis 
Phospholipase Ag resides on the inside of the plasma membrane 
of platelets. To determine if sonification to produce inverted 
membrane vesicles was required to produce maximal PLA activity 
using the assay described in papers II and III, several alternate 
methods of preparation of platelets for the PLA assay were tested and 
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Figure 1. Effect of pH on release of [1-14C] arachidonic acid 
from 1- Palmltoyl-2-[l-l^C] arachidony 1- ao-glycerol-
3-phosphatidyI choline in whole rat platelets 
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from 1- Palmitoyl-2-[l-14c] arachidonyl-j/z-glycerol-
3-phosphatidyl choline in whole human platelets 
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results were compared with the results obtained using unsonicated 
platelets. 
For rat platelets, four methods of platelet preparation were 
tested. The first method was as described in paper II of this 
dissertation (unsonicated platelets). The second method employed 
three 10-second intervals of sonication at 30% power using a Branson 
sonifier equipped with a microtip-probe. The sample tube was kept 
on ice during sonication to prevent heating. The third method 
employed freezing the sample on dry ice and rapidly thawing it In a 
Z7X water bath to fragment the cells before sonication which was 
done as described for the second method. The fourth method was the 
same as the third, except that the frozen, thawed, and sonicated 
platelet sample was centrlfuged at 3000 X g for 30 minutes to remove 
any whole platelets remaining after these treatments. PLA activity 
was assayed using these four sample preparations as described in 
paper II, substituting the different platelet preparations for the 
platelets suspended In TRIS/NaCl buffer as required. To determine the 
effects of these treatments on thromboxane (TX) synthesis in rat 
platelets, aliquots of the incubation mixture were added to aspirin as 
described in paper II and frozen for later assay of TX. 
The results of preparing platelets for the PLA assay as described 
above are shown in Figure 3. There was no significant difference in 
PLA activity due to preparation technique, indicating that the 
radioactive substrate was delivered to the PLA enzyme adequately in 
all preparations. This may be due to the inclusion of the biological 
detergent taurocholic acid in the assay system. However, the time 
course for the synthesis of TX was markedly affected by the different 
methods of platelet preparation (Figure 4). The higher values for TX 
synthesis at the 0 minute time point for all sonicated samples 
indicates that sonication induces TX synthesis in rat platelets. 
Freezing the platelets, followed by sonication, seemed to almost totally 
reduce TX synthesis as the PLA assay progressed over the hour 
interval. The highest TX synthesis was associated with unfrozen 
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Figure 3. Effect of sonication, freezing, and centrifugation (to 
remove whole cells) on release of [1-14C] arachidonic 
acid from 1- Palmitoyl-2-[l-^4c] arachidony 1-
glycerol-3-phosphatidyl choline in rat platelets 
(pH 7.5) 
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sonicated platelets. However, the induction of TX synthesis by 
sonication indicated by these data made the choice of using 
unsonicated whole platelets for the assay in platelets of rats fed 
experimental diets seem best to reflect in vivo conditions. 
Human platelets were observed to have lower PLA activity than 
rat platelets. To determine if this difference was due to inaccessibility 
of the radioactive substrate to the PLA enzyme two tests were done. 
The first test repeated the testing of the effects of different 
methods of platelet preparation on PLA activity using human 
platelets in place of rat platelets. The different methods used to 
prepare the platelets were the same as used for rat platelets 
described above. The results of this investigation are shown in Figure 
5. Again, there was no large difference in PLA activity due to sample 
preparation. Thromboxane synthesis was not determined for these 
assay conditions. However, for consistency and for the reasons 
delineated above regarding assay pH, PLA was assayed in human 
platelets as had been done previously for rat platelets. 
A second test was performed after the completion of the human 
study and associated assays. It was questioned whether uptake of 
radioactive substrate was causing the difference between the two 
species. Therefore, whole platelets in pH 7.5 TRIS/NaCl buffer from 
two individuals of each species were assayed for PLA activity as 
described in Papers II and III (without collagen stimulation). In 
addition to the performance of the assay as described in these papers, 
and in lieu of adding aliquots to aspirin for TX analyses, 50 fil aliquots 
of the assay mixture were added to 1 ml TRIS/NaCl buffer after 40 
minutes incubation and centrifuged at 3000 X g for 30 minutes to 
sediment the platelets. Radioactivity associated with the cell pellet 
and the supernatant was determined by liquid scintillation counting 
as described in Paper III. In both species, about half of the 
radioactivity was in each fraction at 40 min, yet the difference in 
activity between the species was similar to that observed and 
reported in Papers II and III of this dissertation (Table 1), These 
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Table 1. Human and rat platelet phospholipase Ag activity 
and substrate uptake 
Phospholipase Ag Substrate Uptake 
Activity^ | 
Human 1 69 51.7 
Human 2 78 53,4 
Rat 1 345 49.6 
Rat 2 298 51.2 
^Release of [1-14C] arachidonic acid from 1- Palmitoyl-2-[l-l^C] 
arachidonyl-6y?-glycerol-3-phosphatidyl choline in 40 minutes. 
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results, along with the results of the tests of different methods of 
platelet preparation, indicate that the difference between rat and 
human platelet PLA activity observed in the studies reported in this 
dissertation are not due to differences in uptake of radioactive 
substrate. 
Lowry Protein Assay 
All of the data for TX synthesis and PLA activity reported in 
this dissertation are expressed as per mg platelet protein. The assay 
described by Lowry et al, (1951) was used to determine the protein 
content of all samples. The reagents used to perform this assay 
were: 
Reagent A: 2% NagCOs in 0.1 NaOH 
Reagent Bi: 2Sg Sodium Potassium Tartarate (Rochelle Salt) 
Reagent Bs: 1% Copper Sulfate 
Reagent C: 100 ml reagent A with 1 ml each of reagents Bi 
and B2 added (prepared the day of assay). 
2 N Folin and Ciocalteu's Phenol Reagent (Sigma) 
Protein Standard: 100 mg Bovine Serum Albumen Fraction V 
(Fatty Acid-Free)/100 ml water 
The procedure used was as follows: Aliquots (5, 10, 20, 30, 40, and 50 
mD of the standard solution were pipetted Into 10 X 75 mm tubes, 
Sample aliquots (usually 10 or 20 lil) were pipetted into other tubes. 
Water was pipetted to make a total volume of 200 ^1 in each tube. 
Two ml fresh reagent C was added to each tube and the tubes were 
vortexed. After waiting 10 minutes, 100 \xl Folin and Ciocalteu's 
Phenol reagent was added while vortexlng. Color was developed by 
allowing the samples to sit in a dark cabinet for 40 minutes. 
Absorbance at 660 nm (wavelength) was determined using a Gilford 
spectrophotometer (Model 252, equipped with a Beckman Model DU 
optical bench). The amount of protein in each sample was calculated 
by determination of a regression equation from the standard curve. 
An example of a standard curve is shown in Figure 6. Any sample 
that had an absorbance reading greater than the top point of the 
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Standard curve was repeated using less sample. Blanks were done 
using the buffer in which the samples were suspended and sample 
absorbances were corrected by subtraction of this blank absorbance as 
required. All samples were done in duplicate, 
Thromboxane B2 Radioimmunoassay 
Thromboxane A2 synthesized by platelets is spontaneously 
converted to its inactive metabolite, thromboxane B2 (TX). The 
concentration of TX in samples was determined using a double 
antibody radioimmunoassay. 
The reagents used in this assay were; 
0.1 M Phosphate Buffered Saline (PBS): 8.2 g ^ NaCl, 
0.394 g % NaH2P04 • H2O, 1.85 g % Na2HP04 • H2O, and 
0.1 g % Ethyl mercurithiosalicylic acid (sodium salt) 
adjusted to pH 7,0 with HCl, 
PBS gel: 1 g % Knox gelatin in PBS, 
PBS-EDTA: 1.86 g % NagEDTA in PBS, adjusted to pH 7,0 
Normal Rabbit Serum (NRS): obtained from unimmunized 
rabbits and used to determine background binding of 
labeled TX in this assay system; diluted to 1/400 in PBS-
EDTA for use. 
with NaOH. 
Primary Antibody: Rabbit antibody to TX, A gift from 
Mel vin M. Mathias at Colorado State University, Fort 
Collins, CO. Made using Freund's Adjuvent to stimulate 
antibody production; diluted to 1/400 in PBS-EDTA and 
further diluted with 1/400 NRS to give 30% binding to 
3h labeled TX in this assay system. Stored at -20X 
Second Antibody: Anti-Rabbit Gamma Globulin (ARGG) (goat): 
purchased from Western Chemical Research Corp,, Fort 
Collins, CO; diluted to give 30% binding to labeled TX in 
this assay system. Stored at -20®C. 
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Standard TX: A gift from Upjohn, stored at -20X In ethanol 
(2 pg/ml); diluted to 20 ng/ml In PBS-gel for use. 
Labeled TX: (New England Nuclear) Stored at -BOX. 
This assay was performed over 3 days, On the first day, 
diluted anti-TX and diluted AR6G were mixed In a one to one ratio 
and refrigerated overnight. Diluted MRS and diluted ARGG were also 
mixed in a one to one ratio and refrigerated overnight. The 
overnight incubation allowed binding of ARGG to the anti-TX antibody. 
On the second day, samples were diluted, as required, and pipetted 
into 4 ml polypropylene tubes. Standards were pipetted using 500, 
250, 125, 62.5, 31.2, 15.6, 7.8, 3.9, 2, and 1 ^1 of the 20 ng/ml TX 
standard. PBS-gel was added to each tube to make a total volume of 
0.5 ml in each tube. Tubes for background binding and total binding 
contained 0.5 ml PBS-gel. A 0.4 ml aliquot of antl-TX.ARGG prepared 
the first day was added to all tubes except the background tubes, to 
which a 0.4 ml aliquot of NRS:ARGG prepared the first day was 
added. Finally a 0.1 ml aliquot of ^H-TX having approximately 10,000 
counts per minute (cpm) was added to each tube. An equal amount 
of ^H-TX was added to other tubes (total count tubes) to determine 
total counts per minute added to each tube. The tubes were gently 
mixed in racks, covered with parafilm, and refrigerated overnight. 
The third day, 3 ml of PBS was added to all tubes except the total 
count tubes. All tubes except the total count tubes were centrifuged 
at 3000 X g for 30 minutes. The supernatant was poured off and the 
tubes were blotted on absorbent paper, To each tube, including the 
total counts tubes, 0.3 ml water and 3.7 ml Bioscintiverse HP or 
Scintiverse BD (Fisher) were added. Tubes were capped and vortexed 
until clear. Radioactivity as cpm was determined using a Packard 
Tri-carb Liquid Scintillation Counter (Model C2425) using the 
channel, counting for either 4 minutes or until 10,000 counts were 
measured. 
This assay worked by competition for binding sites on anti-TX 
by ^H-TX and sample or stai^idard. The ARGG served to make the 
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anti-TX more dense so that it was pelleted by the centrlfugation step, 
When more standard TX or sample TX was present, less ^h-TX was 
bound, and vice versa. A computer program was used to determine 
the concentration of TX in the samples by comparison with a 
standard curve of binding to Antibody:ARGG. A theoretical standard 
curve was also generated by this program and actual curves were 
compared to this theoretical curve to assure that the assay was 
working as expected, An example of a standard curve for this assay 
is shown in Figure 7, Total binding refers to the percent of ^H-TX 
which was bound when no standard or sample was present. The 
percent binding on the Y-axis of this graph refers to the percent of 
total binding for each standard. All samples and standards were 
done in duplicate. All total count determinations were done in 
triplicate, All total binding determinations were done with six 
replicates. 
The proper titers for anti-TX and AR<3G antibody dilutions were 
determined using the procedure outlined above for determination of 
total binding, with various dilutions of each antibody. For assays, 
ARGG was usually diluted 1/20 and anti-TX was usually diluted 1/1000 
to give between 20 and 30% total binding. Titer checks were always 
done within a week before the assay of sample to assure that the 
assay was working properly. 
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Figure 7. Standard curve of radioimmunoassay for 
thromboxane B2 showing theoretical and actual 
curve data (Antibody; 1/1500 Anti-thromboxane 02, 
Second antibody: 1/60 Anti-Rabbit-Gamma-
Globulin, Total binding: 23.62) 
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APPENDIX B. EXAMPLES OF FORMS COMPLETED BY HUMAN 
SUBJECTS 
128 
Form A: 24 Hour Food Consumption Record 
Record all food and beverages (except water) consumed 
beginning after awakening in the morning and ending when you 
retire for the day that evening. Please record everything consumed, 
including bread spreads, salad dressings, butter on foods, condiments, 
and all similar items; an incomplete record is unacceptable. Use 
approximate units consumed which are appropriate to the food or 
beverage (ie. cups or ounces for beverages; cups for casseroles, salads, 
cereals, etc.; ounces in weight for meats and cheeses; slices for breads, 
cakes, etc.) Please note the size of serving for each food or beverage 
recorded. Use the back of this form if you need more space. Thank 
you. 
Date Name (I.D. Code: ) 
(Leayg Blank)! Food or Beverage Consumed 
L 
Amount Consumed 
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Form B: Diet Questionnaire 
Your Name (I.D. Code: ) 
1. Circle the number corresponding to the kind of animal product 
you consume as part of your usual diet. How often do you eat 
this type of product? (Use as a frequency code: twice or more 
daily = 8, daily = 7, 3 to 6 times per week = 6, once a week = 5, 
2 or 3 times per month = 4, once a month = 3, 2 to 6 times per 
year = 2, yearly = 1, never = 0.) 
0. No animal products. 
1. Dairy Products. Frequency code: 
2. Eggs. Frequency code: 
3. Fish. Frequency code: 
4. Poultry. Frequency code: 
5. Red Meats (Pork, Beef, or Lamb). Frequency code: 
6. Organ Meats (Liver, Kidneys, etc.). Frequency code: 
2. How long have you consumed the diet type reflected by your 
answer to Question 1? 
1. Less than one month. 
2. More than one month but less than six months, 
3. More than six months but less than one year. 
4. More than one year but less than five years. 
5. More than five years but not all my life. 
6. All my life. 
3. Do you take any diet supplements (vitamins, minerals, or other 
supplements)? 
0. No. 
1. Yes. (If you answer yes, please list those you take and 
how often you take them on the back of this questionaire. 
Please copy the label listing of the supplement composition for 
each dose.) 
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4. Have you lost or gained weight in the last year? 
0. No. 
1. Lost weight: pounds. 
2. Gained weight: pounds. 
5. Have you had a serious illness requiring a doctor's treatment in 
the last year? 
0. No. 
1. Yes. Please explain: 
6. What is your race? 
7. Please list any medications, drugs, or other non-food substance 
that you regularly use or consume. 
8. How often do you exercise? How strenuously? 
Form C: Informed Consent 
Studies using rats which have been fed experimental diets 
which vary only in fatty acid composition have shown that platelet 
fatty acid composition is dependent upon the fatty acid composition of 
the diet fed. The platelet fatty acid composition affects the platelet 
Phospholipase A2 activity and platelet Thromboxane synthesis, but 
not regulation of intracellular calcium. This study will attempt to 
show that the same relationships exist in humans. 
To determine the dietary fatty acid composition of your diet 
two methods of dietary assessment will be used. The first method 
will be the recording of all foods and beverages consumed for three 
one day periods: two week days and one Saturday. The second 
method of dietary assessment will be the completion of a short diet 
questionnaire. After completion of the two dietary assessment tools 
described above, a 14 ml blood sample will be drawn by the principal 
Investigator, Barbara Krumhardt, a registered Medical Technologist 
(M.T.(ASCP), registry number: 129364), at the ISU Student Health 
Center laboratory. These blood samples will be collected in the 
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morning, about one hour after you have eaten breakfast. The 
sample will be drawn into a sterile-disposable syringe with a sterile 
disposable needle. The composition of your breakfast will be recorded. 
Additionally, your blood pressure , height, and weight will be 
measured. The only restriction upon you as subject in this study will 
be that there is to be no use of any analgesic drugs (aspirin, 
ibuprofen, acetaminophen, etc. which are usually components of 
headache, pain, and cold medications) for ten days prior to collection 
of the blood sample. These drugs interfere with platelet enzymes 
and, therefore, would cause a non-dietary induced change in the 
parameters to be assayed. 
You will be compensated with a single payment of $15,00 for 
the time spent completing the two dietary assessment tools and 
donating the blood sample. You will also be given the results of all 
analyses (both dietary assessment and laboratory analyses) if you 
should desire this information, Any question that you might have 
regarding the interpretation of this information will be answered by 
the principal investigator. 
The risks or discomforts which might be incurred by 
participating in this study Include the minimal risk and discomfort 
involved with the blood sample collection, and the discomfort which 
might result from abstinence from the use of analgesic drugs. If you 
find that you require the use of analgesic drugs in the ten days prior 
to the collection of the blood sample, you will be given the 
opportunity to reschedule blood sample collection for a later date or 
to withdraw from the study. Also, you may withdraw consent and 
discontinue participation from the study at any time. All data 
collected will be confidential, 
Emergency treatment of any injuries that may occur as a 
direct result of participation in this research will be treated at the 
Iowa State University Student Health Services, Student Services 
Building, and/or referred to Mary Greeley Hospital or another 
physician. Compensation for treatment of any injuries that may 
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occur as a direct result of participation In this research may or may 
not be paid by Iowa State University depending on the Iowa Tort 
Claims Act. Claims for compensation will be handled by the Iowa 
State University Vice President for Business and Finance. 
I understand the nature of this research and my involvement 
in it. I have been given the opportunity to ask questions and obtain 
informative answers. I hereby consent to participation in this 
research project. 
Signature 
Printed Name 
Date 
Form D: Subject Checklist 
Your Name (Payment Approval: ) 
Check off each item as you have completed it and turn in this sheet 
to Barb Krumhardt for payment approval. Thanks for participating. 
1. Read, sign, and turn in the consent form—Form C. 
2. List your mailing address below for payment, 
STREET ADDRESS CITY STATE ZIPCODE 
3. List your social security number (required by ISU for 
payment), - -
4. Complete, and turn in, three (3) 24 hour food records 
(Form A)—two done on weekdays, one done on Saturday. 
5. Complete, and turn in to Barb, the diet questionnaire-
Form B 
6. Refrain from the use of all analgesic drugs for 10 
days before the blood sampling. Your appointment for blood 
sampling is- Come to the student 
health service laboratory 1 to 2 hours after breakfast; recording the 
breakfast eaten on a new Form A. 
